<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms   - Nanoscale Horizons (RSC Publishing) DOI:10.1039/C8NH00299A</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2019/nh/c8nh00299a"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":91,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */
(()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i<n.length-1;i++)if("object"!=typeof(r=r[n[i]]))return;r=r[n[n.length-1]]}return r}const p={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},m={};function v(e){if(!e)throw new Error("All loader-config objects require an agent identifier!");if(!m[e])throw new Error("LoaderConfig for ".concat(e," was never set"));return m[e]}function b(e,t){if(!e)throw new Error("All loader-config objects require an agent identifier!");m[e]=(0,i.D)(t,p),(0,n.Qy)(e,m[e],"loader_config")}const y=(0,n.mF)().o;var w=r(385),x=r(6818);const A={buildEnv:x.Re,bytesSent:{},queryBytesSent:{},customTransaction:void 0,disabled:!1,distMethod:x.gF,isolatedBacklog:!1,loaderType:void 0,maxBytes:3e4,offset:Math.floor(w._A?.performance?.timeOrigin||w._A?.performance?.timing?.navigationStart||Date.now()),onerror:void 0,origin:""+w._A.location,ptid:void 0,releaseIds:{},session:void 0,xhrWrappable:"function"==typeof w._A.XMLHttpRequest?.prototype?.addEventListener,version:x.q4},E={};function T(e){if(!e)throw new Error("All runtime objects require an agent identifier!");if(!E[e])throw new Error("Runtime for ".concat(e," was never set"));return E[e]}function _(e,t){if(!e)throw new Error("All runtime objects require an agent identifier!");E[e]=(0,i.D)(t,A),(0,n.Qy)(e,E[e],"runtime")}function D(e){return function(e){try{const t=s(e);return!!t.licenseKey&&!!t.errorBeacon&&!!t.applicationID}catch(e){return!1}}(e)}},9567:(e,t,r)=>{r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u<s.length;++u)f(s[u],c);(0,i.D)(c,(function(e,t){(0,i.D)(t,(function(t,r){r[0].on(e,r[1])}))}))}delete a[t],r.backlog[t]=null,r.emit("drain-"+t,[])}}r.every((e=>{let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;f<d;f++)s[f].apply(a,r);var l=T()[c[e]];return l&&l.push([p,e,r,a]),a}}function b(e,t){n[e]=w(e).concat(t)}function y(e,t){var r=n[e];if(r)for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)}function w(e){return n[e]||[]}function x(t){return f[t]=f[t]||e(p,t)}function A(e,t){var r=T();p.aborted||(0,o.D)(e,(function(e,n){t=t||"feature",c[n]=t,t in r||(r[t]=[])}))}function E(e){return!!T()[c[e]]}function T(){return p.backlog}}(void 0,"globalEE"),c.ee=u)},5546:(e,t,r)=>{r.d(t,{E:()=>n,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s<e;s++)a.push(o(r,++i).toString(16));return a.join("")}function c(){return s(16)}function u(){return s(32)}},7056:(e,t,r)=>{r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c<t.length;c++)d(a=e[s=t[c]])||(e[s]=r(a,u?s+n:n,i,s,o))},r.flag=i,r;function r(t,r,n,a,s){return d(t)?t:(r||(r=""),nrWrapper[i]=t,u(t,nrWrapper,e),nrWrapper);function nrWrapper(){var i,u,d,f;try{u=this,i=[...arguments],d="function"==typeof n?n(i,u):n||{}}catch(t){c([t,"",[i,u,a],d],e)}o(r+"start",[i,u,a],d,s);try{return f=t.apply(u,i)}catch(e){throw o(r+"err",[i,u,e],d,s),e}finally{o(r+"end",[i,u,f],d,s)}}}function o(r,n,i,o){if(!a||t){var s=a;a=!0;try{e.emit(r,n,i,t,o)}catch(t){c([t,r,n,i],e)}a=s}}}function c(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function u(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach((function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})})),t}catch(e){c([e],r)}for(var n in e)o.call(e,n)&&(t[n]=e[n]);return t}function d(e){return!(e&&e instanceof Function&&e.apply&&!e[i])}var f=r(2210),l=r(385);const h={},g=XMLHttpRequest,p="addEventListener",m="removeEventListener";function v(e){var t=function(e){return(e||n.ee).get("events")}(e);if(h[t.debugId]++)return t;h[t.debugId]=1;var r=s(t,!0);function i(e){r.inPlace(e,[p,m],"-",o)}function o(e,t){return e[1]}return"getPrototypeOf"in Object&&(l.il&&b(document,i),b(l._A,i),b(g.prototype,i)),t.on(p+"-start",(function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var i=(0,f.X)(n,"nr@wrapped",(function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n}));this.wrapped=e[1]=i}})),t.on(m+"-start",(function(e){e[1]=this.wrapped||e[1]})),t}function b(e,t){let r=e;for(;"object"==typeof r&&!Object.prototype.hasOwnProperty.call(r,p);)r=Object.getPrototypeOf(r);for(var n=arguments.length,i=new Array(n>2?n-2:0),o=2;o<n;o++)i[o-2]=arguments[o];r&&t(r,...i)}var y="fetch-",w=y+"body-",x=["arrayBuffer","blob","json","text","formData"],A=l._A.Request,E=l._A.Response,T="prototype",_="nr@context";const D={};function N(e){const t=function(e){return(e||n.ee).get("fetch")}(e);if(!(A&&E&&l._A.fetch))return t;if(D[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[_]&&o[_].dt&&(e=o[_].dt);var a=i.apply(this,r);return t.emit(n+"start",[r,e],a),a.then((function(e){return t.emit(n+"end",[null,e],a),e}),(function(e){throw t.emit(n+"end",[e],a),e}))})}return D[t.debugId]=1,x.forEach((e=>{r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c<a;c++)s[c]=arguments[c];s[0]=o(s[0],"cb-",i,null,!1),s[1]=o(s[1],"cb-",i,null,!1);const u=n.apply(this,s);return i.nextPromise=u,t.emit("propagate",[e,!0],u,!1,!1),u},a.prototype.then[i]=n,t.on("executor-start",(function(e){e[0]=o(e[0],"resolve-",this,null,!1),e[1]=o(e[1],"resolve-",this,null,!1)})),t.on("executor-err",(function(e,t,r){e[1](r)})),t.on("cb-end",(function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)})),t.on("propagate",(function(e,r,n){this.getCtx&&!r||(this.getCtx=function(){if(e instanceof Promise)var r=t.context(e);return r&&r.getCtx?r.getCtx():this})}))}(),t}const B={},F="requestAnimationFrame";function U(e){const t=function(e){return(e||n.ee).get("raf")}(e);if(!l.il||B[t.debugId]++)return t;B[t.debugId]=1;var r=s(t);return r.inPlace(window,[F],"raf-"),t.on("raf-start",(function(e){e[0]=r(e[0],"fn-")})),t}const q={},G="setTimeout",V="setInterval",X="clearTimeout",W="-start",Z="-",$=[G,"setImmediate",V,X,"clearImmediate"];function Q(e){const t=function(e){return(e||n.ee).get("timer")}(e);if(q[t.debugId]++)return t;q[t.debugId]=1;var r=s(t);return r.inPlace(l._A,$.slice(0,2),G+Z),r.inPlace(l._A,$.slice(2,3),V+Z),r.inPlace(l._A,$.slice(3),X+Z),t.on(V+W,(function(e,t,n){e[0]=r(e[0],"fn-",null,n)})),t.on(G+W,(function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)})),t}var Y=r(50);const K={},J=["open","send"];function ee(e){var t=e||n.ee;const r=function(e){return(e||n.ee).get("xhr")}(t);if(K[r.debugId]++)return r;K[r.debugId]=1,v(t);var i=s(r),o=k.Yu.XHR,a=k.Yu.MO,c=k.Yu.PR,u=k.Yu.SI,d="readystatechange",f=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],h=[],g=l._A.XMLHttpRequest.listeners,p=l._A.XMLHttpRequest=function(e){var t=new o(e);function n(){try{r.emit("new-xhr",[t],t),t.addEventListener(d,b,(0,P.m$)(!1))}catch(e){(0,Y.Z)("An error occured while intercepting XHR",e);try{r.emit("internal-error",[e])}catch(e){}}}return this.listeners=g?[...g,n]:[n],this.listeners.forEach((e=>e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e<h.length;e++)m(0,h[e]);h.length&&(h=[])}function E(e,t){return t}return r}},7825:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i<r;i++)n[i]=arguments[i];return function(t){for(var r=arguments.length,n=new Array(r>1?r-1:0),i=1;i<r;i++)n[i-1]=arguments[i];let o=[];return Object.values(e.initializedAgents).forEach((e=>{e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of <".concat(typeof t,"> was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of <".concat(typeof e,"> was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of <".concat(typeof e,"> was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var f=u[d];if(f.getAttribute("src")==r||f.getAttribute("data-webpack")==t+o){s=f;break}}s||(c=!0,(s=document.createElement("script")).charset="utf-8",s.timeout=120,i.nc&&s.setAttribute("nonce",i.nc),s.setAttribute("data-webpack",t+o),s.src=r),e[r]=[n];var l=(t,n)=>{s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u<a.length;u++)o=a[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=window.webpackChunkNRBA=window.webpackChunkNRBA||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})();var o={};(()=>{i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i<e.length;i++)t[r=e[i]]=A(this.aggregatedData[r]),t[r].length&&(n=!0),delete this.aggregatedData[r];return n?t:null}}function w(e,t){return null==e?function(e){e?e.c++:e={c:1};return e}(t):t?(t.c||(t=x(t.t)),t.c+=1,t.t+=e,t.sos+=e*e,e>t.max&&(t.max=e),e<t.min&&(t.min=e),t):{t:e}}function x(e){return{t:e,min:e,max:e,sos:e*e,c:1}}function A(e){return"object"!=typeof e?[]:(0,b.D)(e,E)}function E(e,t){return t}var T=i(8632),_=i(4402),D=i(4351);var N=i(7956),O=i(3239),j=i(9251);class S extends h{static featureName=j.t;constructor(e,r){let n=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i<n.allowed_origins.length;i++){var o=(0,X.e)(n.allowed_origins[i]);if(e.hostname===o.hostname&&e.protocol===o.protocol&&e.port===o.port){r=!0;break}}return r}isDtEnabled(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.enabled}excludeNewrelicHeader(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.cors_use_tracecontext_headers}}var Z=i(7825),$=["load","error","abort","timeout"],Q=$.length,Y=t.Yu.REQ,K=c._A.XMLHttpRequest;class J extends h{static featureName=Z.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s<Q;s++)t.addEventListener($[s],this.listener,(0,O.m$)(!1))}function f(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function l(e,t){var r=""+G(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function h(e,t){var r=""+G(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,p.z)()}function m(e,t){t instanceof K&&"load"===e[0]&&n.emit("xhr-load-added",[e[1],e[2]],t)}function v(e,t){t instanceof K&&"load"===e[0]&&n.emit("xhr-load-removed",[e[1],e[2]],t)}function b(e,t,r){t instanceof K&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,p.z)()))}function y(e,t){this.xhrCbStart&&n.emit("xhr-cb-time",[(0,p.z)()-this.xhrCbStart,this.onload,t],t)}function w(e){var t,r=e[1]||{};"string"==typeof e[0]?t=e[0]:e[0]&&e[0].url?t=e[0].url:c._A?.URL&&e[0]&&e[0]instanceof URL&&(t=e[0].href),t&&(this.parsedOrigin=(0,X.e)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=o.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if("string"==typeof e[0]||c._A?.URL&&e[0]&&e[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),s(i.headers,n)&&(this.dt=n),e.length>1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o<Q;o++)t.removeEventListener($[o],this.listener,!1);r.aborted||(n.duration=(0,p.z)()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==r.status&&(r.status=0):_(this,t),n.cbTime=this.cbTime,i("xhr",[r,n,this.startTime,this.endTime,"xhr"],this,e.D.ajax))}}function T(e,t){var r=(0,X.e)(t),n=e.params;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}function _(e,t){e.params.status=t.status;var r=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?V(e.response):"text"===r||""===r||void 0===r?V(e.responseText):void 0}(t,e.lastSize);if(r&&(e.metrics.rxSize=r),e.sameOrigin){var n=t.getResponseHeader("X-NewRelic-App-Data");n&&(e.params.cat=n.split(", ").pop())}e.loadCaptureCalled=!0}n.on("new-xhr",a),n.on("open-xhr-start",s),n.on("open-xhr-end",u),n.on("send-xhr-start",d),n.on("xhr-cb-time",f),n.on("xhr-load-added",l),n.on("xhr-load-removed",h),n.on("xhr-resolved",g),n.on("addEventListener-end",m),n.on("removeEventListener-end",v),n.on("fn-end",y),n.on("fetch-before-start",w),n.on("fetch-start",x),n.on("fn-start",b),n.on("fetch-done",A)}(r,this.ee,this.handler,this.dt),this.importAggregator())}}var ee=i(3614);const{BST_RESOURCE:te,RESOURCE:re,START:ne,END:ie,FEATURE_NAME:oe,FN_END:ae,FN_START:se,PUSH_STATE:ce}=ee;var ue=i(7836);const{FEATURE_NAME:de,START:fe,END:le,BODY:he,CB_END:ge,JS_TIME:pe,FETCH:me,FN_START:ve,CB_START:be,FN_END:ye}=ue;var we=i(4649);class xe extends h{static featureName=we.t;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})();</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Chunmei Wang"/><meta name="DC.Creator" content="Chen Dai"/><meta name="DC.Creator" content="Zhongqian Hu"/><meta name="DC.Creator" content="Hongqiang Li"/><meta name="DC.Creator" content="Luodan Yu"/><meta name="DC.Creator" content="Han Lin"/><meta name="DC.Creator" content="Jianwen Bai"/><meta name="DC.Creator" content="Yu Chen"/><meta name="DC.title" content="Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2019/02/25"/><meta name="DC.Identifier" scheme="doi" content="10.1039/C8NH00299A"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms  "/><meta name="citation_author" content="Chunmei Wang"/><meta name="citation_author" content="Chen Dai"/><meta name="citation_author" content="Zhongqian Hu"/><meta name="citation_author" content="Hongqiang Li"/><meta name="citation_author" content="Luodan Yu"/><meta name="citation_author" content="Han Lin"/><meta name="citation_author" content="Jianwen Bai"/><meta name="citation_author" content="Yu Chen"/><meta name="citation_online_date" content="2018/10/10"/><meta name="citation_date" content="2019"/><meta name="citation_journal_title" content="Nanoscale Horizons"/><meta name="citation_volume" content="4"/><meta name="citation_issue" content="2"/><meta name="citation_firstpage" content="415"/><meta name="citation_lastpage" content="425"/><meta name="citation_doi" content="10.1039/C8NH00299A"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2019/nh/c8nh00299a"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2019/nh/c8nh00299a"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2019/nh/c8nh00299a"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2019/nh/c8nh00299a">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:c8nh00227d)" href="/en/content/articlehtml/2019/nh/c8nh00227d" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:c8nh00307f)" href="/en/content/articlehtml/2019/nh/c8nh00307f" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div> </div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/C8NH00299A">10.1039/C8NH00299A</a>
(Communication)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2055-6764/2016">Nanoscale Horiz.</a></span>, 2019, <strong>4</strong>, 415-425</div><h1 id="sect200"><span class="title_heading">Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
      <span class="bold">
        
          
            Chunmei 
            Wang<a title="Select to navigate to footnote" href="#fn2">‡</a>
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Chen 
            Dai<a title="Select to navigate to footnote" href="#fn2">‡</a>
          
        
      </span><sup><span class="sup_ref italic">b</span></sup>, 
      <span class="bold">
        
          
            Zhongqian 
            Hu
          
        
      </span>*<sup><span class="sup_ref italic">c</span></sup>, 
      <span class="bold">
        
          
            Hongqiang 
            Li
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Luodan 
            Yu
          
        
      </span><sup><span class="sup_ref italic">d</span></sup>, 
      <span class="bold">
        
          
            Han 
            Lin
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Han Lin (orcid.org/0000-0003-1663-5468) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-1663-5468"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">d</span></sup>, 
      <span class="bold">
        
          
            Jianwen 
            Bai
          
        
      </span>*<sup><span class="sup_ref italic">a</span></sup><span class="bold"> and </span>
      <span class="bold">
        
          
            Yu 
            Chen
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Yu Chen (orcid.org/0000-0002-8206-3325) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-8206-3325"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">d</span></sup>
      <br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">Department of Emergency Medicine and Critical Care, Shanghai East Hospital, Tong Ji University, Shanghai 200120, People's Republic of China. E-mail: <a href="mailto:baijianwen1019@163.com">baijianwen1019@163.com</a></span>
      <br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">Department of Ultrasound, Shanghai East Hospital, Tong Ji University, Shanghai 200120, People's Republic of China</span>
      <br/><a id="affc"><sup><span class="sup_ref italic">c</span></sup></a><span class="italic">Department of Ultrasound, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, People's Republic of China. E-mail: <a href="mailto:hzq920@126.com">hzq920@126.com</a></span>
      <br/><a id="affd"><sup><span class="sup_ref italic">d</span></sup></a><span class="italic">State Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, People's Republic of China. E-mail: <a href="mailto:chenyu@mail.sic.ac.cn">chenyu@mail.sic.ac.cn</a></span>
    </p><div id="art-admin"><span class="italic bold">Received 
      12th September 2018
    </span><span class="bold italic">, Accepted 10th October 2018</span></div><p class="bold italic">First published on 10th October 2018</p><hr/><div class="abstract"><h2>Abstract</h2><p>Light-activated photoacoustic imaging (PAI) and photothermal therapy (PTT) using the second near-infrared biowindow (NIR-II, 1000–1350 nm) hold great promise for efficient tumor detection and diagnostic imaging-guided photonic nanomedicine. In this work, we report on the construction of titanium nitride (TiN) nanoparticles, with a high photothermal-conversion efficiency and desirable biocompatibility, as an alternative theranostic agent for NIR-II laser-excited photoacoustic (PA) imaging-guided photothermal tumor hyperthermia. Working within the NIR-II biowindow provides a larger maximum permissible exposure (MPE) and desirable penetration depth of the light, which then allows detection of the tumor to the full extent using PA imaging and complete tumor ablation using photothermal ablation, especially in deeper regions. After further surface polyvinyl-pyrrolidone (PVP) modification, the TiN–PVP photothermal nanoagents exhibited a high photothermal conversion efficiency of 22.8% in the NIR-II biowindow, and we further verified their high penetration depth using the NIR-II biowindow and their corresponding therapeutic effect on the viability of tumor cells <span class="italic">in vitro</span>. Furthermore, these TiN–PVP nanoparticles were developed as a contrast agent for NIR-II-activated PA imaging both <span class="italic">in vitro</span> and <span class="italic">in vivo</span> for the first time and realized efficient photothermal ablation of the tumor <span class="italic">in vivo</span> within both the NIR-I and NIR-II biowindows. This work not only provides a paradigm for TiN–PVP photothermal nanoagents working in the NIR-II biowindow both <span class="italic">in vitro</span> and <span class="italic">in vivo</span>, but also proves the feasibility of PAI and PTT cancer theranostics using NIR-II laser excitation.</p></div><hr/>
    
      <br/><table class="box_border"><tr><td>
        
          <h2 id="sect305"><span class="a_heading">Conceptual insights</span></h2>
          <span>As one of the most promising cancer therapy modalities, nanoagent-enabled photothermal cancer ablation is highly promising because of its noninvasiveness, controllability and high efficiency. The ability to fabricate high-performance photo-responsive nanoagents with a desirable photothermal-conversion efficiency and photo-responsive wavelength range will determine the future therapeutic outcome, and is of high significance for potential clinical translation. This work has achieved intriguing near infrared-triggered photothermal cancer hyperthermia based on novel titanium nitride nanoplatforms using the NIR-II biowindow, which provides a larger maximum permissible exposure and desirable penetration depth of the light compared to the traditional NIR-I biowindow. Especially and importantly, contrast-enhanced photoacoustic cancer imaging in the NIR-II biowindow has also been realized using these as-designed titanium nitride nanoplatforms as the contrast agents. The demonstrated high biocompatibility and biosafety further guarantee the clinical-translation potential of these titanium nitride nanoplatforms as photo-responsive nanoagents for photonic cancer hyperthermia.</span>
        
      </td></tr></table><br/>
    
    
      <h2 id="sect308"><span class="a_heading">Introduction</span></h2>
      <span>The fast development of advanced nanotechnology and novel nanoplatforms has triggered and propelled numerous well-designed proposals and strategies for efficient cancer therapy.<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1–8</span></sup></a> Compared to conventional treatments such as surgical removal, radiotherapy and chemotherapy, photothermal therapy (PTT), as one of the most promising and effective approaches for cancer ablation and hyperthermia, has attracted great attention in recent years.<a title="Select to navigate to reference" href="#cit9"><sup><span class="sup_ref">9–16</span></sup></a> By employing light as an external and remote stimulus to generate heat, PTT features versatile advantages, such as easy localization, minimal invasiveness, tumor specificity, desirable controllability and a high therapeutic efficacy. To achieve efficient PTT, the photothermal-conversion nanoagents should be carefully designed and engineered, and the examples include well-constructed Au nanoparticles,<a title="Select to navigate to reference" href="#cit17"><sup><span class="sup_ref">17–19</span></sup></a> transition-metal dichalcogenides,<a title="Select to navigate to reference" href="#cit20"><sup><span class="sup_ref">20–23</span></sup></a> black phosphorous,<a title="Select to navigate to reference" href="#cit24"><sup><span class="sup_ref">24–26</span></sup></a> MXenes,<a title="Select to navigate to reference" href="#cit27"><sup><span class="sup_ref">27,28</span></sup></a> graphene and its derivatives,<a title="Select to navigate to reference" href="#cit29"><sup><span class="sup_ref">29–34</span></sup></a> and even some organic nanoagents.<a title="Select to navigate to reference" href="#cit35"><sup><span class="sup_ref">35,36</span></sup></a> Most studies have focused on designing and developing photothermal-conversion nanoagents with either a strong light absorption or high photothermal-conversion efficiency when using visible and short-wavelength near-infrared light (NIR-I, 750–1000 nm).<a title="Select to navigate to reference" href="#cit10"><sup><span class="sup_ref">10,37–40</span></sup></a> However, the human tissue is a highly scattering medium for electromagnetic waves in the optical spectrum. When it comes to tumors in deeper sites, these photothermal nanoagents that work in the NIR-I biowindow don’t perform well because of heavy loss of laser energy on passing though the human body. To overcome this critical issue, utilization of light excitation within the second NIR (NIR-II) biowindow (1000–1350 nm) is preferable based on the potential for a satisfactory penetration depth of the tissue, with less light absorption, for efficient deep-located tumor therapies.</span>
      <p class="otherpara">To optimize therapeutic efficiency and monitor therapeutic responses, bestowing the photothermal-conversion nanoagents with a concurrent diagnostic-imaging function and therapeutic ability is necessary.<a title="Select to navigate to reference" href="#cit41"><sup><span class="sup_ref">41–46</span></sup></a> Fluorescence imaging provides safe and real-time detection along with the key advantage of its high spatial resolution.<a title="Select to navigate to reference" href="#cit47"><sup><span class="sup_ref">47–50</span></sup></a> This benefit of high resolution unfortunately comes at the expense of limited tissue penetration. Photoacoustic imaging (PAI) based on optical excitation and ultrasonic detection is an emerging diagnostic-imaging modality.<a title="Select to navigate to reference" href="#cit51"><sup><span class="sup_ref">51–58</span></sup></a> Specifically, after the nanoprobes absorb the excitation light, they generate acoustic pressure waves which can be detected by the external equipment and utilized for photoacoustic (PA) imaging. Compared to traditional optical-imaging technology that suffers from high scattering of the electromagnetic waves by the human tissues, PAI can break through the optical diffusion limit with much less scattering of the ultrasonic waves, providing high spatial resolution and real-time <span class="italic">in vivo</span> imaging without using any ionizing radiation. Great efforts have been made to explore new PA nanoprobes, such as carbon nanotubes,<a title="Select to navigate to references" href="#cit59"><sup><span class="sup_ref">59</span></sup></a> Au nanorods,<a title="Select to navigate to references" href="#cit60"><sup><span class="sup_ref">60</span></sup></a> methylene blue dye,<a title="Select to navigate to references" href="#cit61"><sup><span class="sup_ref">61</span></sup></a><span class="italic">etc.</span> However, similar to the PTT nanoagents, the main efforts have been devoted only to the design of NIR-I biowindow-excited PA contrast agents (CAs). There is a paucity of research on NIR-II-induced PA CAs, which result in blindness for deep tumor tissues or a certain degree of abnormal tissue morphology in the early stage of a tumor, impeding their further use in the clinic. Therefore, it is highly desirable to explore novel NIR-II biowindow-activated PA nanoagents for deep-site tumor detection and simultaneous achievement of efficient tumor-photothermal ablation.</p>
      <p class="otherpara">Titanium nitride (TiN), an excellent conductive material, has been extensively used in many fields from solar thermoelectric generators to plasmon-mediated photocatalysis.<a title="Select to navigate to reference" href="#cit62"><sup><span class="sup_ref">62–64</span></sup></a> It has been noted that both the titanium and nitrogen components in titanium nitride are highly biocompatible, therefore, it is expected to exert some specific functionalities in biomedical applications.<a title="Select to navigate to references" href="#cit65"><sup><span class="sup_ref">65</span></sup></a> In this work, to overcome the limited penetration depth of light and optimize the therapeutic efficiency, TiN nanoparticles (TiN NPs) with a simple composition and high photothermal-conversion efficiency were explored to serve as both PAI and PTT nanoagents using a NIR-II laser stimulus to activate these photothermal-conversion nanoagents. After further surface engineering using polyvinyl-pyrrolidone (PVP) molecules, the TiN–polyvinyl-pyrrolidone NPs (designated TiN–PVP NPs) exhibited high stability under physiological conditions, guaranteeing their further evaluation and application <span class="italic">in vitro</span> and <span class="italic">in vivo</span>. With a broad band absorption covering the entire UV-vis-NIR range from 300 to 1200 nm, the photothermal-conversion efficiency of the TiN–PVP NPs utilising the NIR-II (1064 nm) biowindow was calculated to be as high as 22.8%, which is sufficiently high for tumor photo-ablation. Furthermore, for comparison with the NIR-I biowindow, <span class="italic">in vitro</span> evaluation of the laser tissue-penetration depth using the NIR-II biowindow and investigation of the corresponding thermal effect on the viability of tumor cells have also been performed, demonstrating that working with the NIR-II biowindow can provide a larger maximum permissible exposure (MPE) and desirable tissue-penetration depth of the light. Especially, highly effective <span class="italic">in vivo</span> photoacoustic and photothermal therapies induced by the TiN–PVP NPs have been successfully demonstrated using the NIR-II biowindow.</p>
    
    
      <h2 id="sect336"><span class="a_heading">Results and discussion</span></h2>
      
        <h3 id="sect338"><span class="b_heading">Synthesis and characterization of the TiN–PVP NPs</span></h3>
        <span>The extinction coefficient (<span class="italic">ε</span>) and photothermal-conversion efficiency (<span class="italic">η</span>) are the two main parameters to consider for desirable photothermal nanoagents. The extinction coefficient indicates the light-absorption performance of the agents and the corresponding photothermal-conversion efficiency displays their ability in converting the absorbed light into heat. TiN has shown a high optical absorption (about 95%) over a broad range and has exhibited plasmonic resonance in the biological-transparency window and high heating efficiencies in the NIR-I biowindow.<a title="Select to navigate to references" href="#cit63"><sup><span class="sup_ref">63</span></sup></a> Therefore, it is expected that TiN NPs would also be endowed with a high photothermal-conversion ability and potential for photothermal hyperthermia using the NIR-II biowindow where irradiation using a NIR-II (<span class="italic">e.g.</span>, 1064 nm) laser would provide higher tissue penetration. To improve the stability of TiN NPs under physiological conditions, polyvinyl-pyrrolidone (PVP), as a broadly explored biocompatible organic molecule, was employed to engineer the surface of TiN NPs (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1a and b</a>). The as-constructed TiN–PVP NPs with high biosafety, and a desirable extinction coefficient and photothermal-conversion efficiency, could be used to achieve NIR-II-activated PA imaging-guided PTT for <span class="italic">in vivo</span> photothermal tumor ablation (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1c and d</a>).</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2019/NH/c8nh00299a/c8nh00299a-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8nh00299a-f1.tif" src="/image/article/2019/NH/c8nh00299a/c8nh00299a-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">(a) The microstructure and surface modification of TiN using organic PVP molecules. (b) Schematic illustration of <span class="italic">in vivo</span> NIR-II-induced PA imaging employing TiN–PVP NPs as the CA. (c) Schematic illustration of the theranostic function of TiN–PVP NPs, <span class="italic">i.e.</span>, NIR-II-excited PA imaging-guided efficient PT ablation of a tumor.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">The SEM image of the obtained TiN NPs shows an irregular elliptical morphology with an average diameter of 25 nm (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2a</a>). TEM images at different magnifications exhibit the small egg-like topology of these nanoagents (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2b and c</a>). The high-resolution TEM (HRTEM) image and corresponding selected area electron diffraction (SAED) pattern clearly show the crystalline lattice and corresponding cubic TiN phase (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2d</a>). The bright-field, dark-field and secondary electron SEM images (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2e–g</a>) of the TiN NPs further evidence their small-sized nanostructure and slightly irregular topology. X-ray energy dispersive spectroscopy (EDS) of the TiN NPs confirmed the presence of Ti and N elements (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2h</a>). The X-ray diffraction (XRD) pattern for the TiN NPs is shown in <a title="Select to navigate to figure" href="#imgfig2">Fig. 2i</a>. The characteristic diffraction peaks at 36.7, 42.5, 61.9, 74.1 and 78.04° are indexed to the (111), (200), (220), (311) and (222) crystal faces of TiN, respectively, further indicating the well-crystalline microstructure and the formation of a cubic TiN phase. X-ray photoelectron spectroscopy (XPS) was carried out to analyze the chemical state of the elements in the TiN NPs. The XPS results further indicate the presence of typical Ti and N signals (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2j</a>). The high resolution XPS spectrum for Ti 2p in air-exposed TiN evidenced the presence of a thin oxidized overlayer on the TiN NPs. The peaks around 464.5 and 458.9 eV for Ti 2p were indexed to Ti–N and Ti–O bonds (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2k</a>),<a title="Select to navigate to references" href="#cit65"><sup><span class="sup_ref">65</span></sup></a> respectively, which agrees with the co-existence of TiN and TiO<small><sub>2</sub></small>.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2019/NH/c8nh00299a/c8nh00299a-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8nh00299a-f2.tif" src="/image/article/2019/NH/c8nh00299a/c8nh00299a-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">Structure, morphology and composition characterization of the TiN NPs. (a) SEM image of the TiN NPs. (b and c) TEM images of the TiN NPs at different magnifications. (d) High-resolution TEM (HRTEM) image of the TiN NPs. Inset shows the SAED pattern for the TiN NPs. (e) Dark-field, (f) bright-field, and (g) secondary electron SEM images of the TiN NPs. (h) X-ray energy dispersive spectroscopy (EDS) spectrum of the TiN NPs. (i) XRD pattern for the TiN NPs. (j) X-ray photoelectron spectroscopy (XPS) results for the TiN NPs. (k) High-resolution XPS spectrum for Ti 2p of the TiN NPs.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">In addition, the TiN NPs showed high hydrophilicity and dispersity in water because of the presence of surface oxygenic TiO<small><sub>2</sub></small> components, which resulted in the easy formation of hydrophilic groups on the surface. However, the TiN NPs easily aggregated in physiological solutions, which would possibly result in fast removal out of the body by the reticular phagocytic system (RES). To address this critical issue, typical biocompatible organic molecules, PVP, were utilized to engineer the surface of the TiN NPs, which bestowed these TiN NPs with excellent stability and high dispersity in various physiological environments, including in phosphate buffer saline (PBS), simulated body fluid (SBF) and Dulbecco's Modified Eagle's Medium (DMEM), which is mainly attributed to the steric hindrance of the organic chains (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3a</a>). The hydrodynamic size of the TiN NPs, as determined by dynamic light scattering (DLS), was around 150 nm (Fig. S1, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>), indicating slight aggregation of these NPs. Fortunately, after surface modification with PVP, the hydrodynamic size of the TiN–PVP NPs was substantially reduced to about 70 nm because of the improved dispersity (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3b</a>). The changes in zeta potential after PVP modification further confirmed successful grafting of the PVP molecules on the surface of the TiN NPs (Fig. S2, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2019/NH/c8nh00299a/c8nh00299a-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8nh00299a-f3.tif" src="/image/article/2019/NH/c8nh00299a/c8nh00299a-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">(a) Digital images of the TiN–PVP NPs dispersed in different physiological solutions. (b) DLS of the TiN–PVP NPs in aqueous solution. (c) UV-vis spectra of the TiN NPs and TiN–PVP NPs dispersed in aqueous solution at a concentration of 100 ppm. (d) Normalized absorbance intensity at <span class="italic">λ</span> = 1064 nm divided by the characteristic length of the cell (<span class="italic">A</span>/<span class="italic">L</span>) at elevated concentrations of the TiN and TiN–PVP NPs. (e and i) The photothermal-heating curves and (f and j) the corresponding temperature and thermal images of the TiN NPs and TiN–PVP NPs, respectively, at elevated concentrations (50, 100, 200 ppm) under 1064 nm laser irradiation at a power density of 1.0 W cm<small><sup>−2</sup></small>. (g and k) Photothermal effect of the aqueous dispersions of TiN and TiN–PVP NPs under 1064 nm laser irradiation (1.0 W cm<small><sup>−2</sup></small>). (h and l) Time constant plots for heat transfer with the TiN and TiN–PVP NPs.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        <h3 id="sect378"><span class="b_heading">Optical absorption and photothermal performance of the TiN–PVP NPs</span></h3>
        <span>Typically, desirable photothermal-conversion nanoagents for PTT have a strong absorption of NIR light and high photothermal-conversion efficiency. Based on this fact, we initially obtained the extinction coefficient (<span class="italic">ε</span>) of the TiN and TiN–PVP NPs for the NIR-II biowindow. It is shown (Fig. S3 (ESI<a title="Select to navigate to footnote" href="#fn1">†</a>) and <a title="Select to navigate to figure" href="#imgfig3">Fig. 3c</a>) that both the TiN and TiN–PVP NPs have a broad band in the NIR region. The extinction coefficient of TiN at 1064 nm was calculated to be as high as 17.34 L g<small><sup>−1</sup></small> cm<small><sup>−1</sup></small> (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3d</a>), which is much higher than that of traditional Au nanorods at 808 nm (13.9 L g<small><sup>−1</sup></small> cm<small><sup>−1</sup></small>)<a title="Select to navigate to references" href="#cit66"><sup><span class="sup_ref">66</span></sup></a> or GO (3.6 L g<small><sup>−1</sup></small> cm<small><sup>−1</sup></small>).<a title="Select to navigate to references" href="#cit30"><sup><span class="sup_ref">30</span></sup></a> After PVP modification, the extinction coefficient of TiN–PVP at 1064 nm reached an even higher value of 22.0 L g<small><sup>−1</sup></small> cm<small><sup>−1</sup></small>, mainly attributed to the improved dispersity of the NPs in aqueous solution through PVP modification.</span>
        <p class="otherpara">Then, the <span class="italic">in vitro</span> photothermal performance of the TiN and TiN–PVP NPs was assessed (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3e, f, i, j</a> and Fig. S4, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). The results exhibited the concentration/laser power-dependent photothermal features of the TiN–PVP NPs. The maximum temperature of the aqueous solution containing the TiN NPs reached 56 °C at a power density of 1.0 W cm<small><sup>−2</sup></small> after 300 s of irradiation and reached about 59 °C after PVP modification under the same conditions, indicating PVP modification only had a slight influence on the photothermal performance of the TiN NPs. The photothermal stability of the TiN–PVP NPs under 1064 nm laser irradiation at a power density of 1.0 W cm<small><sup>−2</sup></small> was further evaluated. No obvious changes were observed on elevating the temperature after 5 cycles (Fig. S4, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). According to the results for the maximum temperature in the steady environment and the time constant for heat transfer during the cooling period, the photothermal-conversion efficiency (<span class="italic">η</span>) values of TiN and TiN–PVP under 1064 nm laser irradiation were calculated to be 22.7% and 22.8%, respectively, both of which are higher than those of representative Au nanorods (21%)<a title="Select to navigate to references" href="#cit67"><sup><span class="sup_ref">67</span></sup></a> and Cu<small><sub>2−<span class="italic">x</span></sub></small>Se NCs (22%)<a title="Select to navigate to references" href="#cit68"><sup><span class="sup_ref">68</span></sup></a> for the NIR-I biowindow (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3g–i and k</a>). These results demonstrate the strong NIR absorption and high photothermal-conversion efficiency (<span class="italic">η</span>) of the TiN–PVP NPs and that surface modification with PVP exhibited no significant effect on the photothermal-conversion efficiency (<span class="italic">η</span>).</p>
        <p class="otherpara">The photothermal performance of the TiN–PVP NPs and the tissue-penetrating capability using the NIR-I and NIR-II biowindows were further assessed by determining the heating curve and the residual laser power density after penetrating the tissues under NIR-I and NIR-II laser irradiation, where chicken breast tissues with a varied thickness (0, 2.5 mm and 5 mm) were used as the model biological tissue (Fig. S5, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). 808 nm and 980 nm laser irradiations were used as NIR-I laser sources and 1064 nm laser irradiation was used as a typical NIR-II laser source. An aqueous solution of TiN–PVP NPs (200 ppm) and chicken breast muscles of varying thicknesses (0, 2.5 mm and 5 mm) were analyzed, with different laser sources (808 nm, 980 nm and 1064 nm), using continuous laser irradiation (2.0 W cm<small><sup>−2</sup></small>, 5 min). The results showed that the maximum temperature of the TiN–PVP aqueous solution under 808 nm, 980 nm and 1064 nm laser irradiation reached rapidly up to nearly 76 °C, 76 °C and 74 °C, respectively (2.0 W cm<small><sup>−2</sup></small>, 5 min; <a title="Select to navigate to figure" href="#imgfig4">Fig. 4a–c</a>). When the penetration depth through the chicken breast tissues was set at 5 mm, the maximum temperature of the TiN–PVP aqueous solution under 808 nm, 980 nm and 1064 nm laser irradiation was 35.5 °C, 38.8 °C and 43.2 °C, respectively, under the same conditions, which is a notable decrease (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4d</a>). The corresponding power density after penetration through the tissue of 5 mm thickness dropped from 2.0 W cm<small><sup>−2</sup></small> to 0.20 W cm<small><sup>−2</sup></small>, 0.22 W cm<small><sup>−2</sup></small> and 0.33 W cm<small><sup>−2</sup></small> under 808 nm, 980 nm and 1064 nm laser irradiation, respectively (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4e</a>), indicating that less attenuation of the photothermal heating occurred under NIR-II laser irradiation than under NIR-I laser irradiation after penetrating through the same thickness of chicken breast tissue. In addition, when the incident power density was decreased to 1.5 W cm<small><sup>−2</sup></small>, the corresponding residual power density after penetration through the tissue of 5 mm thicknesses dropped from 1.5 W cm<small><sup>−2</sup></small> to 0.15 W cm<small><sup>−2</sup></small>, 0.14 W cm<small><sup>−2</sup></small> and 0.19 W cm<small><sup>−2</sup></small> under 808 nm, 980 nm and 1064 nm laser irradiation, respectively (Fig. S6, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). Furthermore, we also evaluated the <span class="italic">in vitro</span> photothermal performance of the TiN–PVP NPs under 1064 nm laser irradiation at various concentrations with laser power densities of 1.5 and 2.0 W cm<small><sup>−1</sup></small>. Fig. S7 (ESI<a title="Select to navigate to footnote" href="#fn1">†</a>) shows that the TiN–PVP NPs in aqueous solution exhibited concentration/laser power-dependent photothermal features.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig4"><a href="/image/article/2019/NH/c8nh00299a/c8nh00299a-f4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8nh00299a-f4.tif" src="/image/article/2019/NH/c8nh00299a/c8nh00299a-f4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 4 </b> <span id="fig4"><span class="graphic_title">Photothermal heating curves for penetrating through chicken breast tissues of varied thickness (0, 2.5 mm and 5 mm) using (a) 808 nm, (b) 980 nm and (c) 1064 nm laser irradiation (2.0 W cm<small><sup>−2</sup></small>). (d) The highest temperature and (e) residual power density on penetrating through chicken breast tissues of varied thickness (0, 2.5 mm and 5 mm) using 808 nm, 980 nm and 1064 nm laser irradiation (2.0 W cm<small><sup>−2</sup></small>). (f) 3D schematic illustration of using TiN–PVP NPs for 4T1 cell ablation after exposure to NIR-I and NIR-II laser irradiation. (g) Relative viabilities of the 4T1 cells after incubation with increased concentrations of TiN–PVP NPs for 24 h and 48 h. (h) Relative viabilities of the 4T1 cells incubated with TiN–PVP NPs after penetrating through chicken breast tissues of varied thickness (0, 2.5 mm and 5 mm) using 808 nm, 980 nm and 1064 nm laser irradiation (2.0 W cm<small><sup>−2</sup></small>). Error bars are based on the standard deviation (s.d.) of five parallel samples (**<span class="italic">P</span> &lt; 0.01). (i) CLSM images of 4T1 cancer cells stained using calcein AM and PI after different treatments. Images share the same scale bar of 50 μm.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        <h3 id="sect436"><span class="b_heading">
          <span class="italic">In vitro</span> photothermal cell ablation and endocytosis</span></h3>
        <span>The <span class="italic">in vitro</span> cell cytotoxicity of the TiN–PVP NPs as photothermal agents was tested using a standard CCK-8 assay. A 4T1 breast cancer cell line was used as the cell model. Initially, the 4T1 cells were incubated with the TiN–PVP NPs at different increasing concentrations (0, 25, 50, 100, 200 and 400 μg mL<small><sup>−1</sup></small>) for 24 and 48 h. These TiN–PVP NPs showed no obvious toxicity that affected the survival of the 4T1 cells (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4g</a>). Then, the TiN–PVP NPs were assessed as photothermal agents for <span class="italic">in vitro</span> 4T1 cell ablation by exposure to 1064 nm laser irradiation. After 4 h of co-incubation of the 4T1 cells with TiN–PVP NPs (100 μg mL<small><sup>−1</sup></small>), the cancer cells were treated with 1064 nm laser irradiation at different power densities (0, 0.5, 1.0, 1.5 and 2.0 W cm<small><sup>−2</sup></small>) (Fig. S8a, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). The results exhibited that enhanced 4T1 cell ablation was achieved with the 1064 nm laser and elevated power density. In addition, the photothermal ablation efficiency of the TiN–PVP NPs for 4T1 cell ablation at different concentrations from 0 to 180 μg mL<small><sup>−1</sup></small> was also assessed upon 1064 nm laser irradiation (1.0 W cm<small><sup>−2</sup></small>) for 5 min (Fig. S8b, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). It was shown that with increase of the concentration of the TiN–PVP NPs, the viability of the 4T1 cells sharply declined to 28.9% after 1064 nm laser irradiation.</span>
        <p class="otherpara">Furthermore, in order to quantitatively assess the effect of the attenuation difference between NIR-I and NIR-II lasers on the viability of 4T1 tumor cells, we used the aforementioned model of chicken breast tissues of varying thicknesses (0, 2.5 mm and 5 mm). <a title="Select to navigate to figure" href="#imgfig4">Fig. 4h</a> shows that the viability of the 4T1 tumor cells under 808 nm, 980 nm and 1064 nm laser irradiation decreased to about 5.0%, 5.5% and 6.2%, respectively, in the presence of TiN–PVP NPs (2.0 W cm<small><sup>−2</sup></small>, 5 min). When covered with the tissue of 5 mm thickness, the inhibition rate for the 4T1 tumor cells treated with 1064 nm laser irradiation reached 27.9%, which is much higher than the inhibition rate for the 4T1 tumor cells treated with 808 nm (11.4%) or 980 nm (14.6%) laser irradiation, indicating that NIR-II laser irradiation resulted in stronger NIR tissue penetration than NIR-I laser irradiation, and could efficiently ablate more tumor cells which is beneficial for treating deep-seated tumor tissues.</p>
        <p class="otherpara">Additionally, confocal fluorescence images of the 4T1 cancer cells were used to further confirm effective photothermal 4T1 cell death in the presence of TiN–PVP NPs after 808 nm and 1064 nm laser irradiation. The live and dead 4T1 cells were distinguished using calcein-AM and PI co-staining, respectively. After exposure to 808 nm and 1064 nm laser irradiation, it was clearly observed that a large amount of 4T1 cells, after incubation with the TiN–PVP NPs, were killed under both 808 nm and 1064 nm laser irradiation. In contrast, the viability of the 4T1 cells in the other groups displayed no obvious change.</p>
      
      
        <h3 id="sect454"><span class="b_heading">PA-imaging performance of the TiN–PVP NPs using the NIR-II biowindow</span></h3>
        <span>The photoacoustic (PA) effect is the physical basis for PA imaging which refers to the generation of acoustic waves through the absorption of light (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5a</a>). PA imaging which combines ultrasonic resolution with a high light contrast can break through the penetration limitation of traditional optical imaging based on its low tissue-attenuation coefficient.<a title="Select to navigate to reference" href="#cit21"><sup><span class="sup_ref">21,51,58</span></sup></a> Unlike ionizing X-ray radiation, it can afford real-time detection of an <span class="italic">in vivo</span> biological structure and functional information in a non-invasive and non-ionizing manner. NIR-II laser-excited PA imaging can potentially provide deeper <span class="italic">in vivo</span> detection of biological tissue, which has seldom been reported so far. Owing to their high photothermal-conversion performance, the TiN–PVP NPs have shown a high potential for use as contrast-enhanced PA nanoagents. Therefore, we used 808 nm laser irradiation as the NIR-I laser source and 1280 nm laser irradiation as the NIR-II laser source to investigate. <a title="Select to navigate to figure" href="#imgfig5">Fig. 5b and c</a> show that different wavelengths of excitation light within the NIR-I biowindow and NIR-II biowindow were used to collect the PA signals of the TiN–PVP NPs. The excitation wavelengths in the NIR-I and NIR-II biowindows were optimized and fixed at 680 nm and 1270 nm, respectively. The PA images from a series of aqueous solutions of the TiN–PVP NPs (62.5, 125, 250 and 500 ppm) under 808 nm and 1280 nm light excitation were obtained and clearly exhibited that the PA signals of the TiN–PVP NPs have a linear relationship with the TiN concentration (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5d and e</a>).</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig5"><a href="/image/article/2019/NH/c8nh00299a/c8nh00299a-f5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8nh00299a-f5.tif" src="/image/article/2019/NH/c8nh00299a/c8nh00299a-f5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 5 </b> <span id="fig5"><span class="graphic_title">(a) 3D schematic illustration of <span class="italic">in vivo</span> PA imaging. (b) Different wavelengths (from 680 to 970 nm) of excitation light were used to collect the NIR-I PA signals of the TiN–PVP NPs. (c) Different wavelengths (from 1200 to 2000 nm) of excitation light were used to collect the NIR-II PA signals of the TiN–PVP NPs. (d) <span class="italic">In vitro</span> concentration-dependent PA signals of the TiN–PVP NPs under NIR-I laser irradiation. Inset: PA imaging of TiN–PVP NPs in buffer solution under NIR-I laser irradiation. (e) <span class="italic">In vitro</span> concentration-dependent PA signals of the TiN–PVP NPs under NIR-II laser irradiation. Inset: PA imaging of TiN–PVP NPs in buffer solution under NIR-II laser irradiation. (f) <span class="italic">In vivo</span> PA signal values and (g) NIR laser-exited PA imaging of 4T1 tumor-bearing mice after intravenous administration of TiN–PVP NPs over prolonged time intervals.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Based on the desirable <span class="italic">in vitro</span> results, we employed 4T1 tumor-bearing mice as an animal model to assess the <span class="italic">in vivo</span> PA-imaging performance of the TiN–PVP NPs using 1280 nm light excitation. After the tumor volume reached about 50 mm<small><sup>3</sup></small>, the mice were intravenously administered with TiN–PVP NPs (20 mg kg<small><sup>−1</sup></small>), and PA images were acquired at different time points after the injection (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5f and g</a>). It was obviously exhibited that the intensity of the PA signal increased quickly from 0.51 (a.u.) to 1.1 (a.u.) 15 min after injection, under 1280 nm light excitation, mainly because of the efficient accumulation of nanosized TiN–PVP NPs in the tumor region <span class="italic">via</span> a typical EPR effect. The value reached nearly 2.3 (a.u.) 4 h after injection, indicating the high efficiency of TiN–PVP NPs as desirable contrast agents for PA imaging in the NIR-II biowindow. Furthermore, compared to the NIR-I-induced PA signals for tumor imaging, the PA imaging using the NIR-II biowindow showed a higher signal-to-noise ratio.</p>
      
      
        <h3 id="sect476"><span class="b_heading">Efficient <span class="italic">in vivo</span> photothermal ablation of tumors using the TiN–PVP NPs</span></h3>
        <span>The biodistribution of TiN–PVP NPs in the main organs and tumor was investigated before the <span class="italic">in vivo</span> PTT experiments were performed (Fig. S9, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). The results show that the intratumor passive accumulation efficiency of the TiN–PVP NPs was quantified as 1.51% and 0.47% ID g<small><sup>−1</sup></small> after 6 h and 36 h of intravenous injection with 4T1 tumor-bearing mice, respectively. After that, motivated by the high <span class="italic">in vitro</span> PTT efficacy, we further investigated the feasibility of using the TiN–PVP NPs as photothermal agents for both the NIR-I and NIR-II windows for <span class="italic">in vivo</span> photothermal hyperthermia. A 4T1 breast tumor-bearing mouse xenograft was established as the animal model. After the tumor volumes reached nearly ∼80 mm<small><sup>3</sup></small>, the 4T1 tumor-bearing mice were randomly divided into six groups to receive different treatments (<span class="italic">n</span> = 5 per group). The groups were: (1) control group, (2) TiN–PVP group, (3) NIR-I laser group, (4) NIR-II laser group, (5) TiN–PVP + NIR-I laser group and (6) TiN–PVP + NIR-II laser group. 808 nm laser excitation was used as the NIR I laser source and 1064 nm laser excitation was employed as the NIR II laser source. Four hours after injection, the NIR-I laser group, NIR-II laser group, TiN–PVP + NIR-I laser group and TiN–PVP + NIR-II laser group were irradiated using a NIR-I or NIR-II laser (1.5 W cm<small><sup>−2</sup></small>, 10 min). <a title="Select to navigate to figure" href="#imgfig6">Fig. 6a and b</a> exhibit that after intravenous administration of the TiN–PVP NPs, the temperature of the tumors in group (5) increased to ∼55 °C within 10 min, whereas the temperature of the tumors in group (6), under 1064 nm laser irradiation at the same power density of 1.5 W cm<small><sup>−2</sup></small>, reached as high as 60 °C. In contrast, the tumor temperature for mice treated with only 808 nm or 1064 nm laser irradiation only increased slightly by 7–10 °C. After the various treatments, the tumor volumes and body weights of the six groups were recorded every two days (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6c and d</a>) and digital photos of the tumor sites of each group were taken every four days (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6f</a> and Fig. S10, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). After the various treatments, the tumors in group (5) and (6) were eradicated without any recurrence and the mice survived over 50 days post treatment (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6e</a>). In comparison, the tumor volumes of the other four groups increased rapidly and mice death occurred continuously after 20 days post treatment. The average lifespans of the mice in these four groups were remarkably shortened. All the mice showed no obvious weight fluctuation, confirming the negligible adverse effects of these received treatments on the health of mice.</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig6"><a href="/image/article/2019/NH/c8nh00299a/c8nh00299a-f6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8nh00299a-f6.tif" src="/image/article/2019/NH/c8nh00299a/c8nh00299a-f6.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 6 </b> <span id="fig6"><span class="graphic_title">(a) Temperature curves for the tumor sites of 4T1 tumor-bearing nude mice under 808 nm and 1064 nm laser irradiation after intravenous injection of TiN–PVP nanoagents, and (b) corresponding IR thermal images of 4T1 tumor-bearing nude mice with or without intravenous injection of TiN–PVP nanoagents under 808 nm and 1064 nm laser irradiation (1.5 W cm<small><sup>−2</sup></small>) taken at different time intervals. (c) Time-dependent tumor-growth curves for the six groups after receiving different treatments. (d) Time-dependent body-weight curves for the 4T1 tumor-bearing nude mice from six experimental groups after receiving different treatments. (e) Survival rates of the 4T1 tumor-bearing mice within the feeding period after different treatments (<span class="italic">n</span> = 5). (f) Digital images of the tumors from each group at the end of the various treatments. (g) H&amp;E staining, TUNEL staining and Antigen Ki-67 immunofluorescence staining of tumor tissues from each group after the different treatments. All the scale bars are 50 μm.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">For further revealing the mechanism of the photothermal effect, hematoxylin–eosin (H&amp;E) staining, TdT-mediated dUTP Nick-End Labeling (TUNEL) staining and Ki-67 antibody staining of tumor tissues from each group of mice 24 h after the various treatments were conducted. A high level of necrosis of the tumor cells was observed from micrographs of the H&amp;E tumor slices from the TiN–PVP + NIR-I group and TiN–PVP + NIR-II group (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6g</a>), which is also in accordance with the results from TUNEL staining. Comparatively, only insignificant abnormal features were observed in the other four groups. Ki-67 antibody staining was performed to assess the proliferative activities of the tumor cells. Significantly suppressed proliferative activities of the cancer cells from group (5) and group (6) were observed, while the other four groups presented no obvious suppression of tumor-cell proliferation. These results indicate that the TiN–PVP NPs with a high photothermal ablation effect hold high potential for ablating tumors when employing NIR-I or NIR-II laser irradiation for efficient tumor photo-hyperthermia.</p>
      
      
        <h3 id="sect500"><span class="b_heading">
          <span class="italic">In vivo</span> biocompatibility assay of the TiN NPs</span></h3>
        <span>An in-depth investigation of the <span class="italic">in vivo</span> biocompatibility and biosafety of the TiN–PVP NPs was systematically conducted to guarantee their further potential for clinical application. Twenty-four healthy Kunming mice were randomly divided into four groups (<span class="italic">n</span> = 5). The groups were: (1) control group, (2) 5 mg kg<small><sup>−1</sup></small> of TiN–PVP group, (3) 10 mg kg<small><sup>−1</sup></small> of TiN–PVP group and (4) 20 mg kg<small><sup>−1</sup></small> of TiN–PVP group. During the four weeks of testing and feeding, no obvious weight variation or abnormal behavior was observed in these four groups (Fig. S11, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). Afterwards, these mice were sacrificed. The major organs from the various groups of mice were collected for H&amp;E staining and pathological characterization (<a title="Select to navigate to figure" href="#imgfig7">Fig. 7</a>). No obvious shrunken malignant cells, loss of contact or nucleus damage were observed in the examined tissue sections from all four groups, indicating that no significant chronic pathological toxicity or adverse effects were found after injection of the TiN–PVP NPs during the one-month feeding period. A series of blood indexes for all the groups were measured at one month post injection. All the indexes in the three TiN–PVP-treated groups exhibited no obvious abnormality compared to those of the control group without any treatment and the changes among these four groups were of no statistical significance (<a title="Select to navigate to figure" href="#imgfig8">Fig. 8</a>). As evidenced by the desirable <span class="italic">in vivo</span> biosafety results, these TiN–PVP NPs show high promise for further bio-application and possibly further clinical translation.</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig7"><a href="/image/article/2019/NH/c8nh00299a/c8nh00299a-f7_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8nh00299a-f7.tif" src="/image/article/2019/NH/c8nh00299a/c8nh00299a-f7.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 7 </b> <span id="fig7"><span class="graphic_title">H&amp;E-stained tissue sections from the major organs of mice after intravenous injection with different doses of TiN–PVP and after one-month of feeding. All the scale bars are 100 μm.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig8"><a href="/image/article/2019/NH/c8nh00299a/c8nh00299a-f8_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c8nh00299a-f8.tif" src="/image/article/2019/NH/c8nh00299a/c8nh00299a-f8.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 8 </b> <span id="fig8"><span class="graphic_title">The related indexes for mice from each group with different TiN–PVP doses of 0 mg kg<small><sup>−1</sup></small>, 5 mg kg<small><sup>−1</sup></small>, 10 mg kg<small><sup>−1</sup></small> and 20 mg kg<small><sup>−1</sup></small> after intravenous administration and a further one-month of feeding.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
    
    
      <h2 id="sect521"><span class="a_heading">Experimental section</span></h2>
      
        <h3 id="sect523"><span class="b_heading">Synthesis of the TiN–PVP NPs</span></h3>
        <span>The TiN nanoparticles (NPs) were obtained from Beijing Dk Nano Technology Co. Firstly, the pristine TiN samples were dispersed in deionized water for 12 h of sonication to obtain ultrasmall TiN NPs. To further improve the dispersity of the TiN NPs under physiological conditions, the TiN NPs (0.4 g) were dissolved in 60 mL of aqueous solution containing PVP (0.8 g, polyvinylpyrrolidone, average MW 40 000) with gentle stirring at 60 °C for 24 h. The as-prepared TiN–PVP NPs were collected by centrifugation and washed with deionized water and ethanol several times to remove residual PVP molecules.</span>
      
      
        <h3 id="sect526"><span class="b_heading">Characterization</span></h3>
        <span>Transmission electron microscopy (TEM) images and the corresponding X-ray energy dispersive X-ray spectroscopy (EDS) spectrum were acquired using a JEM-2100F electron microscope operated at 200 kV. Scanning electron microscopy (SEM) images were obtained using a field emission Magellan 400 microscope (FEI Company). X-ray diffraction (XRD) was performed on a Rigaku D/MAX-2200 PC XRD system (parameters were as follows: Cu Kα, <span class="italic">λ</span> = 1.54 Å, 40 mA, and 40 kV). The X-ray photoelectron spectroscopy (XPS) spectrum was obtained with ESCAlab250 (Thermal Scientific). UV-vis-NIR absorption spectra were recorded using a UV-3600 Shimadzu UV-vis-NIR spectrometer at room temperature. Size and zeta potential measurements were measured using a Zetasizer Nanoseries (Nano ZS90, Malvern Instrument Ltd). The quantitative analysis of Ti element concentration was performed using inductively coupled plasma-optical emission spectrometry (ICP-OES, Agilent 725, Agilent Technologies, USA). The confocal laser scanning microscopy (CLSM) images were collected using a FV1000 (Olympus Company, Japan). The thermal images were acquired using an infrared thermal imaging instrument (FLIR A325SC camera). The NIR-I laser irradiation was performed by utilizing an 808 nm or 980 nm laser pump (Shanghai Connect Fiber Optics Co.). The NIR-II laser irradiation was carried out by utilizing a 1064 nm laser pump (Shanghai Connect Fiber Optics Co.).</span>
      
      
        <h3 id="sect530"><span class="b_heading">
          <span class="italic">In vitro</span> photothermal performance of the TiN–PVP NPs</span></h3>
        <span>To investigate the <span class="italic">in vitro</span> photothermal performance of the TiN–PVP NPs, aqueous solutions (0.1 mL) of TiN–PVP with different TiN concentrations (0, 22.5, 45, 90 and 180 ppm) were measured and analyzed by continuously irradiating with an 1064 nm NIR laser (Shanghai Connect Fiber Optics Company) at a power density of 1.0 W cm<small><sup>−2</sup></small> for 5 min, respectively. The temperature after different time durations was recorded using a FLIR™ A325SC camera. The detailed calculation for the photothermal-conversion efficiency is provided in the ESI.<a title="Select to navigate to footnote" href="#fn1">†</a></span>
      
      
        <h3 id="sect537"><span class="b_heading">Deep-tissue photothermal performance of the TiN–PVP NPs for both the NIR-I and NIR-II biowindows</span></h3>
        <span>Using the NIR-II biowindow (1000–1350 nm) for phototherapy can achieve an improved penetration depth and larger maximum permissible exposure (MPR), attributed to lower absorption and scattering when passing through biological tissues. Thus, we evaluated the tissue penetration performance using NIR-I and NIR-II laser irradiation by measuring the heat curve and the residual laser energy density after penetrating chicken breast muscles of varied thickness (0, 2.5 mm and 5 mm), which were used as model biological tissues. 808 nm and 980 nm laser irradiations were used to represent a NIR-I light source and 1064 nm laser irradiation represented a NIR-II light source. The deep tissue photothermal performance was evaluated using TiN–PVP NPs with the above chicken breast tissues of different thicknesses of 0, 2.5 mm and 5.0 mm under 808 nm, 980 nm and 1064 nm laser irradiation. 100 μL aliquots of a TiN–PVP NPs aqueous solution in 96 wells covered with chicken breast tissues of different thicknesses were treated with 808 nm, 980 nm and 1064 nm laser irradiation at a power density of 2.0 W cm<small><sup>−2</sup></small> for 5 min, and the infrared thermographs were obtained using a thermal imaging camera.</span>
      
      
        <h3 id="sect541"><span class="b_heading">
          <span class="italic">In vitro</span> cytotoxicity assay</span></h3>
        <span>A murine breast cancer 4T1 cell line (4T1 cells; Cell Bank of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences) was used as the model cell type to assess the <span class="italic">in vitro</span> cytotoxicity of the TiN–PVP NPs. The 4T1 cells were maintained at 37 °C under 5% CO<small><sub>2</sub></small> in Dulbecco's modified Eagle's medium (DMEM, high glucose, GIBCO, Invitrogen) and supplemented with 1% penicillin/streptomycin and 10% fetal bovine serum (FBS) in a humidified incubator. Firstly, the cells (1 × 10<small><sup>5</sup></small> cells per well) were generally plated in 96-well plates for 24 h to allow the cells to adhere, and then the culture medium was replaced with fresh culture medium containing TiN–PVP at different increasing concentrations (0, 25, 50, 100, 200 and 400 μg mL<small><sup>−1</sup></small>). After 24 and 48 h of incubation, the CCK-8 assay was performed to access the viability of the cancer cells (<span class="italic">n</span> = 5).</span>
      
      
        <h3 id="sect550"><span class="b_heading">
          <span class="italic">In vitro</span> photothermal ablation of cancer cells</span></h3>
        <span>4T1 cells (1 × 10<small><sup>5</sup></small> cells per well) were initially cultivated in 96-well plates in DMEM at 37 °C in the presence of 5% CO<small><sub>2</sub></small> over 24 h. Afterwards, the culture medium was discarded and then fresh medium containing TiN–PVP NPs at a TiN concentration of 100 μg mL<small><sup>−1</sup></small> was dispersed into the wells. After 4 h of co-incubation, the above culture medium was discarded and the cells were rinsed several times with PBS (Runcheng Biotech Co., Ltd, Shanghai). After that, the cells were placed under 1064 nm laser irradiation at different power densities (0, 0.5, 1.0, 1.5 and 2.0 W cm<small><sup>−2</sup></small>) for 5 min. Finally, a standard CCK-8 assay was performed to assess the viability of the cells (<span class="italic">n</span> = 5).</span>
      
      
        <h3 id="sect559"><span class="b_heading">
          <span class="italic">In vitro</span> deep-tissue photothermal ablation of cancer cells using both NIR-I and NIR-II biowindows</span></h3>
        <span>4T1 cells (1 × 10<small><sup>5</sup></small> cells per well) were initially cultivated in 96-well plates in DMEM at 37 °C in the presence of 5% CO<small><sub>2</sub></small> over 24 h. Then, the culture medium was replaced with fresh medium containing TiN–PVP NPs at a TiN concentration of 200 μg mL<small><sup>−1</sup></small>. After 4 h of incubation, the <span class="italic">in vitro</span> viability of the cells was investigated under NIR-I and NIR-II laser irradiation, where 808 nm and 980 nm laser pumps were used as a NIR-I light source and a 1064 nm laser pump was used as the NIR-II light source. Chicken breast tissues of different thicknesses of 0 mm, 2.5 mm and 5 mm were used as model biological tissues.</span>
      
      
        <h3 id="sect567"><span class="b_heading">
          <span class="italic">In vitro</span> PTT effect as observed using CLSM</span></h3>
        <span>4T1 cancer cells were initially seeded in CLSM-specific culture dishes for 12 h to adhere overnight at 37 °C in humidified 5% CO<small><sub>2</sub></small>. Then, the medium was discarded and replaced with fresh medium containing the TiN–PVP NPs (200 μg mL<small><sup>−1</sup></small>). After 4 h of incubation, the cells were then exposed to different treatments, including a control group, TiN–PVP only, NIR-I laser only, NIR-II laser only, TiN–PVP + NIR-I laser, and TiN–PVP + NIR-II laser. After that, the cell culture medium was removed and replaced by calcein-AM (100 μL) and PI solution (100 μL, Dojindo Molecular Technologies, Inc.) for another 20 min. Finally, the medium was removed and the cells were rinsed with PBS twice and observed using confocal laser scanning microscopy (CLSM, FV 1000, Olympus), where dead cells were stained in red while live cells were stained in green.</span>
      
      
        <h3 id="sect573"><span class="b_heading">
          <span class="italic">In vitro</span> and <span class="italic">in vivo</span> photoacoustic imaging</span></h3>
        <span>For <span class="italic">in vitro</span> PA imaging, the PA signals for the NIR-I and NIR-II biowindows were obtained using different wavelengths of excitation light from 680 to 970 nm and 1200 to 2000 nm, respectively. Then, TiN–PVP NPs were dispersed into deionized water at different increasing concentrations (0.0625, 0.125, 0.25, and 0.5 mg mL<small><sup>−1</sup></small>) and were utilized for PA signal detection to assess the linearity of the PA signals as a function of TiN–PVP NP concentration. 808 nm laser irradiation was used as the NIR-I excitation light source and 1280 nm laser irradiation was used as the NIR-II excitation light source. Imaging parameters: the region of interest was 20 mm; PA gain, 25 dB; 2D gain, 13 dB; wavelength, 808 nm for NIR-I biowindow, 1280 nm for NIR-II biowindow.</span>
        <p class="otherpara">For <span class="italic">in vivo</span> PA imaging, 4T1 tumor-bearing mice were intravenously administered with TiN–PVP NPs (20 mg kg<small><sup>−1</sup></small>) after the tumor size reached nearly 50 mm<small><sup>3</sup></small>. PA imaging of the 4T1 tumor-bearing mice using both the NIR-I and NIR-II biowindows was performed after intravenous injection of the TiN–PVP NPs. The PA signal before injection was used as the control. The <span class="italic">in vitro</span> and <span class="italic">in vivo</span> PA imaging experiments were performed using a Fujifilm VisualSonics/VEVO LAZR-X PA Imaging System. Imaging parameters: the region of interest was 20 mm; PA gain, 46 dB; 2D gain, 16 dB; wavelength, 808 nm for NIR-I biowindow, 1280 nm for NIR-II biowindow.</p>
      
      
        <h3 id="sect586"><span class="b_heading">
          <span class="italic">In vivo</span> toxicity assay</span></h3>
        <span>The animal experiment procedures were in agreement with the guidelines of the Regional Ethics Committee for Animal Experiments and the care regulations approved by the Administrative Committee of Laboratory Animals of Fudan University. Healthy female Kunming mice (22 g) were obtained and raised at the Laboratory Animal Center, Shanghai Medical College of Fudan University. Twenty mice (4 weeks old) were divided into four groups, followed by the intravenous administration of TiN–PVP NPs at different doses. The groups were: (1) control group (only intravenously injected with saline), (2) 5 mg kg<small><sup>−1</sup></small> of TiN–PVP group, (3) 10 mg kg<small><sup>−1</sup></small> of TiN–PVP group and (4) 20 mg kg<small><sup>−1</sup></small> of TiN–PVP group. The body weight of the mice was recorded every two days. After intravenous administration of the TiN–PVP NPs, on the 30th day, the mice were scarified and blood samples were then collected to conduct a serum biochemistry assay and complete blood panel test. The blood indexes were measured. The major organs of the mice were collected, fixed in 10% formalin, embedded into paraffin, and stained with hematoxylin and eosin (H&amp;E) for histological analysis.</span>
      
      
        <h3 id="sect593"><span class="b_heading">Biodistribution assay of the TiN–PVP NPs</span></h3>
        <span>The biodistribution of the TiN–PVP NPs in main organs and tumors was assessed using 4T1-tumor-bearing mice (<span class="italic">n</span> = 3). The 4T1-tumor-bearing mice were intravenously administered with TiN–PVP NPs at a dose of 20 mg kg<small><sup>−1</sup></small> (0.1 mL). Mice were dissected after 6 h and 36 h after treatment. The dissected organs and tumors were weighed and dissolved with strong acid. The TiN–PVP NP distributions in different tissues were calculated as the percentage of injected dose per gram of tissue.</span>
      
      
        <h3 id="sect598"><span class="b_heading">
          <span class="italic">In vivo</span> photothermal therapy using both the NIR-I and NIR-II biowindows</span></h3>
        <span>Thirty 4 week old female Balb/c nude mice were obtained for <span class="italic">in vivo</span> therapeutic evaluation. These nude mice were injected subcutaneously with 4T1 cells (1 × 10<small><sup>6</sup></small> cells per site) suspended in PBS (100 μL) to develop the tumor model. When the tumor volume reached about 80 mm<small><sup>3</sup></small>, these mice were randomly divided into six groups. The groups were: (1) control group, (2) TiN–PVP group (only intravenously injected with TiN–PVP NPs), (3) NIR-I group (only exposed to NIR-I laser irradiation), (4) NIR-II group (only exposed to NIR-II laser irradiation), (5) TiN–PVP + NIR-I laser group (intravenously injected with TiN–PVP NPs and exposed to NIR-I laser irradiation), (6) TiN–PVP + NIR-II laser group (intravenously injected with TiN–PVP NPs and exposed to NIR-II laser irradiation). 808 nm laser irradiation was used as the NIR-I light source and 1064 nm laser irradiation was used as the NIR-II light source. 4 h after administration of the TiN–PVP NPs, all the mice were anesthetized and <span class="italic">in vivo</span> photothermal ablation was performed. The tumor volumes of the mice were recorded every 2 days according to the following formula: tumor volume = (tumor length) × (tumor width)<small><sup>2</sup></small>/2 and corresponding photographs were taken every 4 days. Afterwards, the tumors were collected from each group and fixed in 10% formalin, followed by H&amp;E, TUNEL, and Ki-67 staining for histological analysis.</span>
      
      
        <h3 id="sect607"><span class="b_heading">Statistical analysis</span></h3>
        <span>The data are presented as mean ± s.d., and the significance of the data in this work was analyzed according to a Kruskal–Wallis test (**<span class="italic">P</span> &lt; 0.01).</span>
      
    
    
      <h2 id="sect611"><span class="a_heading">Conclusions</span></h2>
      <span>In summary, titanium nitride (TiN) NPs with a high photothermal-conversion efficiency and desirable biocompatibility have been successfully developed, for the first time, as an alternative but highly efficient theranostic agent for NIR-II laser-excited PA imaging-guided photothermal hyperthermia of tumors. These TiN–PVP NPs exhibited a broadband absorption covering the entire UV-vis-NIR range from 300 to 1200 nm. After surface PVP functionalization, the TiN–PVP NPs featured high dispersity and excellent biocompatibility under physiological conditions. Especially and importantly, the photothermal-conversion efficiency for the NIR-II (1064 nm) biowindow was calculated to be 22.8%, which is sufficiently high for photo-ablation of tumors. Additionally, the advantages of working with the NIR-II biowindow of a larger maximum permissible exposure (MPE) and desirable penetration depth of the light were evidenced. Especially, the capability of the TiN NPs as a contrast agent for PA imaging using the NIR-II biowindow has been demonstrated both <span class="italic">in vitro</span> and <span class="italic">in vivo</span>, and their high photothermal-conversion performance using the NIR-II biowindow successfully eradicated tumors without reoccurrence from a 4T1 breast cancer xenograft. Therefore, this work not only reveals the high potential of the NIR-II biowindow for photonic cancer nanomedicine, but also provides a novel theranostic nanoplatform (TiN in this work) for efficient cancer phototherapies using the NIR-II biowindow.</span>
    
    
      <h2 id="sect616"><span class="a_heading">Conflicts of interest</span></h2>
      <span>The authors declare no conflicts of interest.</span>
    
  
    <h2 id="sect620"><span class="a_heading">Acknowledgements</span></h2>
      <span>We greatly acknowledge financial support through grants from the National Key R&amp;D Program of China (Grant No. 2016YFA0203700), National Natural Science Foundation of China (Grant No. 81670067, 51672303 and 81501444), Excellent Young Scientist Foundation of NSFC (Grant No. 51722211), Program of Shanghai Subject Chief Scientist (Grant No. 18XD1404300), Shanghai Science and Technology Commission Medical Guidance Project of China (15411962300) and Shanghai Key Medical Discipline for Critical Care Medicine (2017ZZ02012-2).</span>
    
    <span id="sect622"><h2 id="sect619"><span class="a_heading">Notes and references</span></h2></span><ol type="1">
      <li><span id="cit1">J. A. Barreto, W. O'Malley, M. Kubeil, B. Graham, H. Stephan and L. Spiccia, <span class="italic">Adv. Mater.</span>, 2011, <span class="bold">23</span>, H18–H40 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201100140" title="DOI Link to resource 10.1002/adma.201100140">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXjslersLw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21433100%5Buid%5D" title="PubMed Link to resource 21433100">PubMed</a>.</span></li>
      <li><span id="cit2">M. Ferrari, <span class="italic">Nat. Rev. Cancer</span>, 2005, <span class="bold">5</span>, 161–171 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nrc1566" title="DOI Link to resource 10.1038/nrc1566">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXhslSnt7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15738981%5Buid%5D" title="PubMed Link to resource 15738981">PubMed</a>.</span></li>
      <li><span id="cit3">S. Nazir, T. Hussain, A. Ayub, U. Rashid and A. J. MacRobert, <span class="italic">Nanomed. Nanotechnol.</span>, 2014, <span class="bold">10</span>, 19–34 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.nano.2013.07.001" title="DOI Link to resource 10.1016/j.nano.2013.07.001">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhtlersrzO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23871761%5Buid%5D" title="PubMed Link to resource 23871761">PubMed</a>.</span></li>
      <li><span id="cit4">R. Misra, S. Acharya and S. K. Sahoo, <span class="italic">Drug Discovery Today</span>, 2010, <span class="bold">15</span>, 842–850 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.drudis.2010.08.006" title="DOI Link to resource 10.1016/j.drudis.2010.08.006">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXht1KqurrE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20727417%5Buid%5D" title="PubMed Link to resource 20727417">PubMed</a>.</span></li>
      <li><span id="cit5">X. Ai, C. J. Ho, J. Aw, A. B. Attia, J. Mu, Y. Wang, X. Wang, Y. Wang, X. Liu, H. Chen, M. Gao, X. Chen, E. K. Yeow, G. Liu, M. Olivo and B. Xing, <span class="italic">Nat. Commun.</span>, 2016, <span class="bold">7</span>, 10432 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/ncomms10432" title="DOI Link to resource 10.1038/ncomms10432">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xht1ertr4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26786559%5Buid%5D" title="PubMed Link to resource 26786559">PubMed</a>.</span></li>
      <li><span id="cit6">Z. Zhou, J. Song, L. Nie and X. Chen, <span class="italic">Chem. Soc. Rev.</span>, 2016, <span class="bold">45</span>, 6597–6626 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6CS00271D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6CS00271D">RSC</a>.</span></li>
      <li><span id="cit7">W. Zhou, X. Gao, D. Liu and X. Chen, <span class="italic">Chem. Rev.</span>, 2015, <span class="bold">115</span>, 10575–10636 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.chemrev.5b00100" title="DOI Link to resource 10.1021/acs.chemrev.5b00100">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOit7jJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26114396%5Buid%5D" title="PubMed Link to resource 26114396">PubMed</a>.</span></li>
      <li><span id="cit8">Q. Chen, L. Feng, J. Liu, W. Zhu, Z. Dong, Y. Wu and Z. Liu, <span class="italic">Adv. Mater.</span>, 2016, <span class="bold">28</span>, 7129–7136 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201601902" title="DOI Link to resource 10.1002/adma.201601902">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XpsFCmsb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27283434%5Buid%5D" title="PubMed Link to resource 27283434">PubMed</a>.</span></li>
      <li><span id="cit9">M. Chen, S. Tang, Z. Guo, X. Wang, S. Mo, X. Huang, G. Liu and N. Zheng, <span class="italic">Adv. Mater.</span>, 2014, <span class="bold">26</span>, 8210–8216 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201404013" title="DOI Link to resource 10.1002/adma.201404013">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGitLrJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25363309%5Buid%5D" title="PubMed Link to resource 25363309">PubMed</a>.</span></li>
      <li><span id="cit10">H. Lin, X. Wang, L. Yu, Y. Chen and J. Shi, <span class="italic">Nano Lett.</span>, 2017, <span class="bold">17</span>, 384–391 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.nanolett.6b04339" title="DOI Link to resource 10.1021/acs.nanolett.6b04339">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XitFGgt7jJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28026960%5Buid%5D" title="PubMed Link to resource 28026960">PubMed</a>.</span></li>
      <li><span id="cit11">Z. Zhang, J. Wang and C. Chen, <span class="italic">Adv. Mater.</span>, 2013, <span class="bold">25</span>, 3869–3880 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201301890" title="DOI Link to resource 10.1002/adma.201301890">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXovFarsLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24048973%5Buid%5D" title="PubMed Link to resource 24048973">PubMed</a>.</span></li>
      <li><span id="cit12">Q. Chen, L. Xu, C. Liang, C. Wang, R. Peng and Z. Liu, <span class="italic">Nat. Commun.</span>, 2016, <span class="bold">7</span>, 13193 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/ncomms13193" title="DOI Link to resource 10.1038/ncomms13193">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhslGrtrzN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27767031%5Buid%5D" title="PubMed Link to resource 27767031">PubMed</a>.</span></li>
      <li><span id="cit13">Q. Chen, C. Liang, C. Wang and Z. Liu, <span class="italic">Adv. Mater.</span>, 2015, <span class="bold">27</span>, 903–910 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201404308" title="DOI Link to resource 10.1002/adma.201404308">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhtbvF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25504416%5Buid%5D" title="PubMed Link to resource 25504416">PubMed</a>.</span></li>
      <li><span id="cit14">Y. Wang, Y. Deng, H. Luo, A. Zhu, H. Ke, H. Yang and H. Chen, <span class="italic">ACS Nano</span>, 2017, <span class="bold">11</span>, 12134–12144 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b05214" title="DOI Link to resource 10.1021/acsnano.7b05214">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWlsbjI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29141151%5Buid%5D" title="PubMed Link to resource 29141151">PubMed</a>.</span></li>
      <li><span id="cit15">H. Luo, Q. Wang, Y. Deng, T. Yang, H. Ke, H. Yang, H. He, Z. Guo, D. Yu, H. Wu and H. Chen, <span class="italic">Adv. Funct. Mater.</span>, 2017, <span class="bold">27</span>, 1702834 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201702834" title="DOI Link to resource 10.1002/adfm.201702834">CrossRef</a>.</span></li>
      <li><span id="cit16">S. Ye, J. Rao, S. Qiu, J. Zhao, H. He, Z. Yan, T. Yang, Y. Deng, H. Ke, H. Yang, Y. Zhao, Z. Guo and H. Chen, <span class="italic">Adv. Mater.</span>, 2018, e1801216 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201801216" title="DOI Link to resource 10.1002/adma.201801216">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29862592%5Buid%5D" title="PubMed Link to resource 29862592">PubMed</a>.</span></li>
      <li><span id="cit17">H. Liu, T. Liu, X. Wu, L. Li, L. Tan, D. Chen and F. Tang, <span class="italic">Adv. Mater.</span>, 2012, <span class="bold">24</span>, 755–761 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201103343" title="DOI Link to resource 10.1002/adma.201103343">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhs12gtr3L" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22213059%5Buid%5D" title="PubMed Link to resource 22213059">PubMed</a>.</span></li>
      <li><span id="cit18">J. Kim, S. Park, J. E. Lee, S. M. Jin, J. H. Lee, I. S. Lee, I. Yang, J.-S. Kim, S. K. Kim, M.-H. Cho and T. Hyeon, <span class="italic">Angew. Chem., Int. Ed.</span>, 2006, <span class="bold">118</span>, 7918–7922 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ange.200602471" title="DOI Link to resource 10.1002/ange.200602471">CrossRef</a>.</span></li>
      <li><span id="cit19">M. S. Yavuz, Y. Cheng, J. Chen, C. M. Cobley, Q. Zhang, M. Rycenga, J. Xie, C. Kim, K. H. Song, A. G. Schwartz, L. V. Wang and Y. Xia, <span class="italic">Nat. Mater.</span>, 2009, <span class="bold">8</span>, 935–939 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nmat2564" title="DOI Link to resource 10.1038/nmat2564">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlt7rF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19881498%5Buid%5D" title="PubMed Link to resource 19881498">PubMed</a>.</span></li>
      <li><span id="cit20">L. Cheng, J. Liu, X. Gu, H. Gong, X. Shi, T. Liu, C. Wang, X. Wang, G. Liu, H. Xing, W. Bu, B. Sun and Z. Liu, <span class="italic">Adv. Mater.</span>, 2014, <span class="bold">26</span>, 1886–1893 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201304497" title="DOI Link to resource 10.1002/adma.201304497">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOmu7fO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24375758%5Buid%5D" title="PubMed Link to resource 24375758">PubMed</a>.</span></li>
      <li><span id="cit21">X. Qian, S. Shen, T. Liu, L. Cheng and Z. Liu, <span class="italic">Nanoscale</span>, 2015, <span class="bold">7</span>, 6380–6387 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5NR00893J&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5NR00893J">RSC</a>.</span></li>
      <li><span id="cit22">S. S. Chou, B. Kaehr, J. Kim, B. M. Foley, M. De, P. E. Hopkins, J. Huang, C. J. Brinker and V. P. Dravid, <span class="italic">Angew. Chem., Int. Ed.</span>, 2013, <span class="bold">52</span>, 4160–4164 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201209229" title="DOI Link to resource 10.1002/anie.201209229">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXjslKrsb8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23471666%5Buid%5D" title="PubMed Link to resource 23471666">PubMed</a>.</span></li>
      <li><span id="cit23">Y. Yong, L. Zhou, Z. Gu, L. Yan, G. Tian, X. Zheng, X. Liu, X. Zhang, J. Shi, W. Cong, W. Yin and Y. Zhao, <span class="italic">Nanoscale</span>, 2014, <span class="bold">6</span>, 10394–10403 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4NR02453B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4NR02453B">RSC</a>.</span></li>
      <li><span id="cit24">C. Sun, L. Wen, J. Zeng, Y. Wang, Q. Sun, L. Deng, C. Zhao and Z. Li, <span class="italic">Biomaterials</span>, 2016, <span class="bold">91</span>, 81–89 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2016.03.022" title="DOI Link to resource 10.1016/j.biomaterials.2016.03.022">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XksVOgsLs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27017578%5Buid%5D" title="PubMed Link to resource 27017578">PubMed</a>.</span></li>
      <li><span id="cit25">G. Yang, Z. Liu, Y. Li, Y. Hou, X. Fei, C. Su, S. Wang, Z. Zhuang and Z. Guo, <span class="italic">Biomaterials</span>, 2017, <span class="bold">5</span>, 2048–2055 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7BM00414A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7BM00414A">RSC</a>.</span></li>
      <li><span id="cit26">Y. Li, Z. Liu, Y. Hou, G. Yang, X. Fei, H. Zhao, Y. Guo, C. Su, Z. Wang, H. Zhong, Z. Zhuang and Z. Guo, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2017, <span class="bold">9</span>, 25098–25106 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.7b05824" title="DOI Link to resource 10.1021/acsami.7b05824">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSjtr3O" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28671452%5Buid%5D" title="PubMed Link to resource 28671452">PubMed</a>.</span></li>
      <li><span id="cit27">H. Lin, Y. Chen and J. Shi, <span class="italic">Adv. Sci.</span>, 2018, 1800518 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/advs.201800518" title="DOI Link to resource 10.1002/advs.201800518">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30356929%5Buid%5D" title="PubMed Link to resource 30356929">PubMed</a>.</span></li>
      <li><span id="cit28">H. Lin, Y. Wang, S. Gao, Y. Chen and J. Shi, <span class="italic">Adv. Mater.</span>, 2018, <span class="bold">30</span>, 1703284 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201703284" title="DOI Link to resource 10.1002/adma.201703284">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29226386%5Buid%5D" title="PubMed Link to resource 29226386">PubMed</a>.</span></li>
      <li><span id="cit29">K. Yang, S. Zhang, G. Zhang, X. Sun, S. T. Lee and Z. Liu, <span class="italic">Nano Lett.</span>, 2010, <span class="bold">10</span>, 3318–3323 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nl100996u" title="DOI Link to resource 10.1021/nl100996u">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXpslWjsbw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20684528%5Buid%5D" title="PubMed Link to resource 20684528">PubMed</a>.</span></li>
      <li><span id="cit30">J. T. Robinson, S. M. Tabakman, Y. Liang, H. Wang, H. S. Casalongue, D. Vinh and H. Dai, <span class="italic">J. Am. Chem. Soc.</span>, 2011, <span class="bold">133</span>, 6825–6831 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja2010175" title="DOI Link to resource 10.1021/ja2010175">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXksVeitb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21476500%5Buid%5D" title="PubMed Link to resource 21476500">PubMed</a>.</span></li>
      <li><span id="cit31">X. Wang, C. Wang, L. Cheng, S. T. Lee and Z. Liu, <span class="italic">J. Am. Chem. Soc.</span>, 2012, <span class="bold">134</span>, 7414–7422 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja300140c" title="DOI Link to resource 10.1021/ja300140c">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggtrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22486413%5Buid%5D" title="PubMed Link to resource 22486413">PubMed</a>.</span></li>
      <li><span id="cit32">Y. Yong, L. Zhou, S. Zhang, L. Yan, Z. Gu, G. Zhang and Y. Zhao, <span class="italic">NPG Asia Mater.</span>, 2016, <span class="bold">8</span>, e273 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/am.2016.63" title="DOI Link to resource 10.1038/am.2016.63">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xot1Khs7g%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit33">K. Yang, J. Wan, S. Zhang, B. Tian, Y. Zhang and Z. Liu, <span class="italic">Biomaterials</span>, 2012, <span class="bold">33</span>, 2206–2214 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2011.11.064" title="DOI Link to resource 10.1016/j.biomaterials.2011.11.064">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xnt1egtw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22169821%5Buid%5D" title="PubMed Link to resource 22169821">PubMed</a>.</span></li>
      <li><span id="cit34">K. Yang, L. Hu, X. Ma, S. Ye, L. Cheng, X. Shi, C. Li, Y. Li and Z. Liu, <span class="italic">Adv. Mater.</span>, 2012, <span class="bold">24</span>, 1868–1872 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201104964" title="DOI Link to resource 10.1002/adma.201104964">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XjtVyiurk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22378564%5Buid%5D" title="PubMed Link to resource 22378564">PubMed</a>.</span></li>
      <li><span id="cit35">J. Li, C. Xie, J. Huang, Y. Jiang, Q. Miao and K. Pu, <span class="italic">Angew. Chem., Int. Ed.</span>, 2018, <span class="bold">57</span>, 3995–3998 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201800511" title="DOI Link to resource 10.1002/anie.201800511">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXkt1Gqu7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29417709%5Buid%5D" title="PubMed Link to resource 29417709">PubMed</a>.</span></li>
      <li><span id="cit36">X. Zhen, C. Xie and K. Pu, <span class="italic">Angew. Chem., Int. Ed.</span>, 2018, <span class="bold">57</span>, 3938–3942 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201712550" title="DOI Link to resource 10.1002/anie.201712550">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXkt1Gqu74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29527761%5Buid%5D" title="PubMed Link to resource 29527761">PubMed</a>.</span></li>
      <li><span id="cit37">H. Lin, S. Gao, C. Dai, Y. Chen and J. Shi, <span class="italic">J. Am. Chem. Soc.</span>, 2017, <span class="bold">139</span>, 16235–16247 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.7b07818" title="DOI Link to resource 10.1021/jacs.7b07818">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhslSitrnM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29063760%5Buid%5D" title="PubMed Link to resource 29063760">PubMed</a>.</span></li>
      <li><span id="cit38">X. Zhu, W. Feng, J. Chang, Y. W. Tan, J. Li, M. Chen, Y. Sun and F. Li, <span class="italic">Nat. Commun.</span>, 2016, <span class="bold">7</span>, 10437 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/ncomms10437" title="DOI Link to resource 10.1038/ncomms10437">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XitlCiurk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26842674%5Buid%5D" title="PubMed Link to resource 26842674">PubMed</a>.</span></li>
      <li><span id="cit39">J. Conde, N. Oliva, Y. Zhang and N. Artzi, <span class="italic">Nat. Mater.</span>, 2016, <span class="bold">15</span>, 1128–1138 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nmat4707" title="DOI Link to resource 10.1038/nmat4707">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygsbzE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27454043%5Buid%5D" title="PubMed Link to resource 27454043">PubMed</a>.</span></li>
      <li><span id="cit40">L. Lin, L. Liu, B. Zhao, R. Xie, W. Lin, H. Li, Y. Li, M. Shi, Y. G. Chen, T. A. Springer and X. Chen, <span class="italic">Nat. Nanotechnol.</span>, 2015, <span class="bold">10</span>, 465–471 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nnano.2015.28" title="DOI Link to resource 10.1038/nnano.2015.28">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXksVCmtbw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25775150%5Buid%5D" title="PubMed Link to resource 25775150">PubMed</a>.</span></li>
      <li><span id="cit41">Z. Liu, F. Pu, S. Huang, Q. Yuan, J. Ren and X. Qu, <span class="italic">Biomaterials</span>, 2013, <span class="bold">34</span>, 1712–1721 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2012.11.009" title="DOI Link to resource 10.1016/j.biomaterials.2012.11.009">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhslGku7nM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23199744%5Buid%5D" title="PubMed Link to resource 23199744">PubMed</a>.</span></li>
      <li><span id="cit42">X. Huang, G. Deng, L. Liao, W. Zhang, G. Guan, F. Zhou, Z. Xiao, R. Zou, Q. Wang and J. Hu, <span class="italic">Nanoscale</span>, 2017, <span class="bold">9</span>, 2626–2632 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6NR09028A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6NR09028A">RSC</a>.</span></li>
      <li><span id="cit43">Z. Li, J. Liu, Y. Hu, K. A. Howard, Z. Li, X. Fan, M. Chang, Y. Sun, F. Besenbacher, C. Chen and M. Yu, <span class="italic">ACS Nano</span>, 2016, <span class="bold">10</span>, 9646–9658 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.6b05427" title="DOI Link to resource 10.1021/acsnano.6b05427">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhsF2gsbzN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27689234%5Buid%5D" title="PubMed Link to resource 27689234">PubMed</a>.</span></li>
      <li><span id="cit44">W. Zhang and C. Gao, <span class="italic">Sci. Bull.</span>, 2015, <span class="bold">60</span>, 1973–1979 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s11434-015-0952-3" title="DOI Link to resource 10.1007/s11434-015-0952-3">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhvFeru73O" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit45">C. Dai, S. Zhang, Z. Liu, R. Wu and Y. Chen, <span class="italic">ACS Nano</span>, 2017, <span class="bold">11</span>, 9467–9480 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b05215" title="DOI Link to resource 10.1021/acsnano.7b05215">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKntrvE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28829584%5Buid%5D" title="PubMed Link to resource 28829584">PubMed</a>.</span></li>
      <li><span id="cit46">C. Dai, Y. Chen, X. Jing, L. Xiang, D. Yang, H. Lin, Z. Liu, X. Han and R. Wu, <span class="italic">ACS Nano</span>, 2017, <span class="bold">11</span>, 12696–12712 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b07241" title="DOI Link to resource 10.1021/acsnano.7b07241">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhvVars7bK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29156126%5Buid%5D" title="PubMed Link to resource 29156126">PubMed</a>.</span></li>
      <li><span id="cit47">H. S. Choi, S. L. Gibbs, J. H. Lee, S. H. Kim, Y. Ashitate, F. Liu, H. Hyun, G. Park, Y. Xie, S. Bae, M. Henary and J. V. Frangioni, <span class="italic">Nat. Biotechnol.</span>, 2013, <span class="bold">31</span>, 148–153 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nbt.2468" title="DOI Link to resource 10.1038/nbt.2468">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXjslagsg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23292608%5Buid%5D" title="PubMed Link to resource 23292608">PubMed</a>.</span></li>
      <li><span id="cit48">S. Gioux, H. S. Choi and J. V. Frangioni, <span class="italic">Mol. Imaging</span>, 2010, <span class="bold">9</span>, 237–255 <a target="_blank" class="DOILink" href="https://doi.org/10.2310/7290.2010.00034" title="DOI Link to resource 10.2310/7290.2010.00034">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhsVejtLbP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20868625%5Buid%5D" title="PubMed Link to resource 20868625">PubMed</a>.</span></li>
      <li><span id="cit49">G. Hong, J. C. Lee, J. T. Robinson, U. Raaz, L. Xie, N. F. Huang, J. P. Cooke and H. Dai, <span class="italic">Nat. Med.</span>, 2012, <span class="bold">18</span>, 1841–1846 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nm.2995" title="DOI Link to resource 10.1038/nm.2995">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ymtr%252FI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23160236%5Buid%5D" title="PubMed Link to resource 23160236">PubMed</a>.</span></li>
      <li><span id="cit50">P. Wang, Y. Fan, L. Lu, L. Liu, L. Fan, M. Zhao, Y. Xie, C. Xu and F. Zhang, <span class="italic">Nat. Commun.</span>, 2018, <span class="bold">9</span>, 2898 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41467-018-05113-8" title="DOI Link to resource 10.1038/s41467-018-05113-8">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30042434%5Buid%5D" title="PubMed Link to resource 30042434">PubMed</a>.</span></li>
      <li><span id="cit51">M. Xu and L. V. Wang, <span class="italic">Rev. Sci. Instrum.</span>, 2006, <span class="bold">77</span>, 041101 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.2195024" title="DOI Link to resource 10.1063/1.2195024">CrossRef</a>.</span></li>
      <li><span id="cit52">X. Wang, X. Xie, G. Ku, L. V. Wang and G. Stoica, <span class="italic">J. Biomed. Opt.</span>, 2006, <span class="bold">11</span>, 024015 <a target="_blank" class="DOILink" href="https://doi.org/10.1117/1.2192804" title="DOI Link to resource 10.1117/1.2192804">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16674205%5Buid%5D" title="PubMed Link to resource 16674205">PubMed</a>.</span></li>
      <li><span id="cit53">Y. J. Liu, L. M. Nie and X. Y. Chen, <span class="italic">Trends Biotechnol.</span>, 2016, <span class="bold">34</span>, 420–433 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.tibtech.2016.02.001" title="DOI Link to resource 10.1016/j.tibtech.2016.02.001">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XisFGquro%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26924233%5Buid%5D" title="PubMed Link to resource 26924233">PubMed</a>.</span></li>
      <li><span id="cit54">P. Beard, <span class="italic">Interface Focus</span>, 2011, <span class="bold">1</span>, 602–631 <a target="_blank" class="DOILink" href="https://doi.org/10.1098/rsfs.2011.0028" title="DOI Link to resource 10.1098/rsfs.2011.0028">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22866233%5Buid%5D" title="PubMed Link to resource 22866233">PubMed</a>.</span></li>
      <li><span id="cit55">S. Wang, J. Lin, T. F. Wang, X. Y. Chen and P. Huang, <span class="italic">Theranostics</span>, 2016, <span class="bold">6</span>, 2394–2413 <a target="_blank" class="DOILink" href="https://doi.org/10.7150/thno.16715" title="DOI Link to resource 10.7150/thno.16715">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXitVWrsb7P" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27877243%5Buid%5D" title="PubMed Link to resource 27877243">PubMed</a>.</span></li>
      <li><span id="cit56">K. Cheng, H. Chen, C. H. Jenkins, G. L. Zhang, W. Zhao, Z. Zhang, F. Han, J. Fung, M. Yang, Y. X. Jiang, L. Xing and Z. Cheng, <span class="italic">ACS Nano</span>, 2017, <span class="bold">11</span>, 12276–12291 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b05966" title="DOI Link to resource 10.1021/acsnano.7b05966">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsLbE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29202225%5Buid%5D" title="PubMed Link to resource 29202225">PubMed</a>.</span></li>
      <li><span id="cit57">L. Y. Cui and J. H. Rao, <span class="italic">Wires. Nanomed. Nanobi.</span>, 2017, <span class="bold">9</span>, e1418 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/wnan.1418" title="DOI Link to resource 10.1002/wnan.1418">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27346564%5Buid%5D" title="PubMed Link to resource 27346564">PubMed</a>.</span></li>
      <li><span id="cit58">L. V. Wang and S. Hu, <span class="italic">Science</span>, 2012, <span class="bold">335</span>, 1458–1462 <a target="_blank" class="DOILink" href="https://doi.org/10.1126/science.1216210" title="DOI Link to resource 10.1126/science.1216210">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XktFWktrw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22442475%5Buid%5D" title="PubMed Link to resource 22442475">PubMed</a>.</span></li>
      <li><span id="cit59">A. De La Zerda, C. Zavaleta, S. Keren, S. Vaithilingam, S. Bodapati, Z. Liu, J. Levi, B. R. Smith, T. J. Ma, O. Oralkan, Z. Cheng, X. Y. Chen, H. J. Dai, B. T. Khuri-Yakub and S. S. Gambhir, <span class="italic">Nat. Nanotechnol.</span>, 2008, <span class="bold">3</span>, 557–562 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nnano.2008.231" title="DOI Link to resource 10.1038/nnano.2008.231">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOqsLvO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18772918%5Buid%5D" title="PubMed Link to resource 18772918">PubMed</a>.</span></li>
      <li><span id="cit60">A. Agarwal, S. W. Huang, M. O'Donnell, K. C. Day, M. Day, N. Kotov and S. Ashkenazi, <span class="italic">J. Appl. Phys.</span>, 2007, <span class="bold">102</span>, 064701 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.2777127" title="DOI Link to resource 10.1063/1.2777127">CrossRef</a>.</span></li>
      <li><span id="cit61">T. N. Erpelding, C. Kim, M. Pramanik, L. Jankovic, K. Maslov, Z. Guo, J. A. Margenthaler, M. D. Pashley and L. V. Wang, <span class="italic">Radiology</span>, 2010, <span class="bold">256</span>, 102–110 <a target="_blank" class="DOILink" href="https://doi.org/10.1148/radiol.10091772" title="DOI Link to resource 10.1148/radiol.10091772">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20574088%5Buid%5D" title="PubMed Link to resource 20574088">PubMed</a>.</span></li>
      <li><span id="cit62">G. R. Li, F. Wang, Q. W. Jiang, X. P. Gao and P. W. Shen, <span class="italic">Angew. Chem., Int. Ed.</span>, 2010, <span class="bold">49</span>, 3653–3656 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201000659" title="DOI Link to resource 10.1002/anie.201000659">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXlvFWis74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20391550%5Buid%5D" title="PubMed Link to resource 20391550">PubMed</a>.</span></li>
      <li><span id="cit63">D. R. Clements, Y. Kim, S. A. Gujar and P. W. K. Lee, <span class="italic">OncoImmunology</span>, 2016, <span class="bold">5</span>(1), e1057674 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/2162402X.2015.1057674" title="DOI Link to resource 10.1080/2162402X.2015.1057674">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26942069%5Buid%5D" title="PubMed Link to resource 26942069">PubMed</a>.</span></li>
      <li><span id="cit64">Y. Yue, P. Han, X. He, K. Zhang, Z. Liu, C. Zhang, S. Dong, L. Gu and G. Cui, <span class="italic">J. Mater. Chem.</span>, 2012, <span class="bold">22</span>, 4938 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2JM16128A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2JM16128A">RSC</a>.</span></li>
      <li><span id="cit65">W. He, K. Ai, C. Jiang, Y. Li, X. Song and L. Lu, <span class="italic">Biomaterials</span>, 2017, <span class="bold">132</span>, 37–47 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2017.04.007" title="DOI Link to resource 10.1016/j.biomaterials.2017.04.007">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXlvVGgt7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28407493%5Buid%5D" title="PubMed Link to resource 28407493">PubMed</a>.</span></li>
      <li><span id="cit66">J. T. Robinson, K. Welsher, S. M. Tabakman, S. P. Sherlock, H. Wang, R. Luong and H. Dai, <span class="italic">Nano Res.</span>, 2010, <span class="bold">3</span>, 779–793 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s12274-010-0045-1" title="DOI Link to resource 10.1007/s12274-010-0045-1">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsbnF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21804931%5Buid%5D" title="PubMed Link to resource 21804931">PubMed</a>.</span></li>
      <li><span id="cit67">J. Zeng, D. Goldfeld and Y. Xia, <span class="italic">Angew. Chem., Int. Ed.</span>, 2013, <span class="bold">52</span>, 4169–4173 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201210359" title="DOI Link to resource 10.1002/anie.201210359">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXktFeis7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23494970%5Buid%5D" title="PubMed Link to resource 23494970">PubMed</a>.</span></li>
      <li><span id="cit68">C. M. Hessel, V. P. Pattani, M. Rasch, M. G. Panthani, B. Koo, J. W. Tunnell and B. A. Korgel, <span class="italic">Nano Lett.</span>, 2011, <span class="bold">11</span>, 2560–2566 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nl201400z" title="DOI Link to resource 10.1021/nl201400z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXlvFClsbY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21553924%5Buid%5D" title="PubMed Link to resource 21553924">PubMed</a>.</span></li>
    </ol>
    
    
    
    
    
  <hr/><table><tr><td><h3>Footnotes</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available. See DOI: <a href="http://xlink.rsc.org/?DOI=c8nh00299a" target="_blank" title="Select to resolve DOI: 10.1039/c8nh00299a">10.1039/c8nh00299a</a></span></span></td></tr><tr><td><span class="sup_ref">‡ <span id="fn2">These authors contributed equally to this work.</span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2019</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>